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Preventive cancer screenings are essential to early detect cancer and subsequently save
lives. However, out-of-pocket expenditures for cancer screening services deter individuals from
obtaining them. In an effort to improve the utilization of cancer screening, the Affordable Care
Act (ACA) implemented a cost-sharing elimination provision that removes all forms of costsharing including copayments, co-insurance and deductibles from certain preventive care services
that are recommended by widely known scientific figures such as the United States Preventive
Services Task Force (USPSTF).
This study evaluated the impact of the ACA cost-sharing elimination provision for
preventive care services from 2008 through 2016 using a differences in differences (DID)
approach. The approach compared utilization changes overtime between the insured (treatment
group) and the uninsured (control group). This study investigated the impact of the ACA costsharing elimination provision on the utilization of three cancer prevention screenings, particularly,
breast, cervical, and colorectal cancer screenings, among individuals who were privately insured
and/or Medicare-insured, before and after the cost-sharing elimination provision enactment. This
provision became effective for private health insurance plans, in 2010, and for Medicare, in 2011.
A focus of this dissertation was to examine the influence of socio-economic and socio-
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demographic factors on utilization changes. These factors were determined with the guidance of
the Andersen Healthcare Utilization model which states that the usage of health services is
determined by the three dynamics: predisposing, enabling, and need factors.
This study utilized data from the national Medical Expenditure Panel Survey (MEPS). The
MEPS is a nationally representative survey of non-institutionalized United States (US) individuals
and families. The results of this dissertation expand the current knowledge of the impact of the
ACA cost-sharing elimination provision on increasing utilization of three cancer screenings and
provides policy makers and health professionals with much needed information for decisionmaking.
The results of this study demonstrate that the ACA cost-sharing elimination provision did
not have an impact on the utilization of the examined cancer screening services including
mammography, Pap smear, FOBT, colonoscopy and sigmoidoscopy. However, there were some
predisposing, enabling, and need factors that showed a significant effect on utilization rates,
suggesting that future research is necessary to understand and evaluate the impact of cost-sharing
on access to cancer preventive care services.
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INTRODUCTION
Increasing the uptake of preventive care screening services for breast, cervical, and
colorectal (CRC) cancer is critical for improving the health of the population because of their high
potential for decreasing the burden of cancer in the United States (US) (Maciosek et al, 2009).
Despite the significant efforts that have been made to increase cancer screenings, screening rates
for breast, cervical, and CRC cancer remain suboptimal with the current rates disappointingly low.
The excessive economic costs of cancer create a burden on individuals and the overall society. In
2015, the Agency for Healthcare Research and Quality (AHRQ) estimated that the total of all
health care costs for cancer in the nation were $80.2 billion. Similarly, a study estimating the
national total cost of cancer care from 2010 to 2020 projected costs to increase to $157.77 billion
in 2020 as a result of an aging population; assuming that incidence, survival, and costs for main
cancer sites would remain constant (Mariotto et al, 2011). In addition to costs, cancer is a deadly
disease, particularly when not identified early. In fact, cancer is the second most common cause of
death in the US after heart disease. This year, about 606,880 Americans will die from cancer,
which is more than 1,670 people a day (American Cancer Society, 2019; Siegel et al, 2019). Given
the high death rate expected from cancer, the role of policy has become fundamental in
implementing policies that promote cancer screenings. One major attempt was the implementation
of the Affordable Care Act (ACA) that included a variety of provision aiming to increase cancer
screening and eventually an early cancer diagnosis and treatment that can save many lives.
The ACA cost-sharing elimination provision for preventive services is one of the
provisions that aims to increase screening rates through the elimination of financial barriers that
are presumed to deter individuals from obtaining the screenings. These financial barriers were
costs incurred by the individuals in various forms including co-payments, deductibles, and
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coinsurance. This provision became effective for private health insurance plans, in 2010, and for
Medicare in 2011. The impact of the ACA cost-sharing elimination policy provision can be
assessed by evaluating the receipt of breast, cervical, and CRC cancer screenings among privately
and Medicare insured adults pre-and post ACA implementation after controlling for certain sociodemographic and socioeconomic factors.
Although previous studies have established that cost-sharing elimination could potentially
increase preventive health services utilization, many of these studies have not investigated sociodemographic and socioeconomic differences, or time trends in preventive services use (Han et al,
2015). Additionally, there are only a few studies which evaluated the effects of cost-sharing on
use of cancer preventive services in national samples (Rezayatmand et al, 2013) and most of the
studies examined only a short period after the ACA because of the unavailability of data. This
dissertation expands the body of knowledge by examining a variety of socio-demographic and
socioeconomic factors that could have a significant impact on the utilization of cancer screenings
particularly, breast, cervical, and CRC cancer screenings, utilizing national data form 2008 through
2016. The study sought to demonstrate the effect of the ACA cost-sharing elimination provision
on cancer screenings rates and disparities among different groups in an effort to provide
information to policy makers and health professionals on the outcome of the cost-sharing
elimination provision. Guided by the well-established Andersen’s Behavioral Model of Health
Services Use (BM) with supporting evidence from the literature, this study identified sociodemographic and socioeconomic factors associated with screening. If the evidence indicates better
health coverage and enhanced access does not lead to the optimal utilization of preventive care
services, exploration of reasons for suboptimal cancer screening rates are explored.
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BACKGROUND AND LITERATURE REVIEW
Preventive health services are vital because they enable early detection of diseases before
the development of clinical symptoms. Lower utilization of preventive services is a major public
health concern especially with the growing number of chronic diseases that are very costly to
manage. On a national level, Americans use only half of the recommended level of preventive care
services (Centers for Disease Control and Prevention (CDC), 2017) attributing to the leading
causes of death, with the first cause of death being the diseases of the heart followed by cancer
(Table 1). In fact, heart diseases and malignant neoplasms are responsible for about half of total
deaths in the nation (CDC, 2015). In total, chronic conditions are responsible for 7 out of 10 deaths
among Americans yearly and account for approximately 75% of the total nation’s health spending.
By 2030, it is estimated that more than 81 million Americans will have at least one chronic illness
(Wu and Green, 2000) with projected costs related to their rising from $1.3 trillion in 2003 to $4.2
trillion by 2023 (Bodenheimer and Bennett, 2009). The leading causes of deaths in the U.S. in
2015 are listed in Table 1.
Table 1. Leading Causes of Death and Number of Deaths: United States, 2015
Cause of Death

Deaths

All causes

2,712,630

Diseases of heart

633,842 (23.4%)

Malignant neoplasms

595,930 (21.9%)

Chronic lower respiratory diseases

155,041 (5.7%)

Unintentional injuries

146,571 (5.4%)

Cardiovascular diseases

140,323 (5.2%)

Alzheimer’s disease

110,561 (4.1%)

Diabetes Mellitus

79,535 (2.9%)

Influenza and pneumonia

57,062 (2.1%)
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Nephritis, nephrotic syndrome, and nephrosis

49,959 (1.8%)

Suicide

44,193 (1.6%)

Source: Centers for Disease Control and Prevention https://www.cdc.gov/nchs/data/hus/hus16.pdf#019

Chronic conditions can be largely preventable through appropriate preventive services and
screenings. A study that examined the health benefits of using nine recommended clinical
preventive services, including mammography, colonoscopy, and the pap smear test, reported that
these screening could prevent the annual death of approximately 25,000 to 40,000 Americans
under 65 years and 50,000 to 100,000 Americans under the age of 80 years (Farley et al, 2010).
Cancer screening services had a lower probability to save lives, with colonoscopy having the
probability to prevent the highest number of deaths, which is 1900 deaths to be avoided each year
for a 10% increase in screenings. Preventive care services could lead to major savings in health
care spending. A study conducted to measure the medical costs and life savings of a package of
twenty evidence-based services including breast, cervical, and CRC cancer screenings showed that
improving the utilization of preventive services to 90% can save the healthcare system $3.7 billion
and 2 million lives annually (Maciosek et al, 2010). It is evident that with increased utilization of
effective preventive services including cancer screenings, many lives would be prevented and
immense costs would be saved.
The Affordable Care Act Cost-Sharing Elimination Provision
Before the implementation of the ACA, many insurance plans required cost-sharing for
preventive services. Insured individuals were responsible for various forms of cost-sharing,
including copayments, co-insurance, and meeting plan deductibles; these charges were often
substantial out-of-pocket expenses for some screening services. Medicare beneficiaries who did
not have supplemental insurance were required to pay 20% of the cost of many preventive services,
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whereas Medicare beneficiaries with supplemental plans (Advantage plans) were responsible to
pay more than this amount (Pyenson et al, 2014). For mammogram, the average out-of-pocket
charge for women with any type of insurance was approximately $33, which was 14.1% of the
total charge ($266) (Lemasters and Sambamoorthi, 2008). Although a $33-dollar charge seems to
be trivial, research has shown that an expense exceeding $10 can deter underserved women from
obtaining screening services, specifically a mammogram (McAlearney et al, 2007). Prior to the
ACA, women who were privately insured or without insurance were found to be more likely to
pay a part or the total cost of a mammogram compared to women who had federal or state insurance
such as Medicare and/or Medicaid (Pagan et al, 2008). Out-of-pocket expenses drastically vary
among different types of cancer screenings. For the pap smear test, the average out-of-pocket
charge for insured individuals ranged from $3 to $11 before the ACA, which was the lowest
amount among the five cancer screenings examined in this study (Goodwin and Anderson, 2012).
Colonoscopy, which is the most common type of CRC cancer screening test, was more expensive
than both the FOBT test and sigmoidoscopy. In 2010, the average cost sharing requirement for
colonoscopy was approximately $334 for privately insured individuals and $275 for Medicare
insured individuals. These cost requirements were a small percent of the total screenings costs of
$2146 (15.6%) and $1071 (25.7%), respectively (Pyenson et al, 2014). On the other hand, the outof-pocket expenses before the ACA ranged from $12 to $23 for a the FOBT test and $55-$171 for
sigmoidoscopy, which were considerably smaller amounts (Goodwin and Anderson, 2012).
A growing body of literature has shown that out-of-pocket expenditures are a major
financial barrier in utilizing preventive care services (Cooper et al, 2016; Rezayatmand et al, 2013;
Trivedi et al, 2008; Koh and Sebelius, 2010; Goodwin and Anderson, 2012). Accordingly, an
emerging body of research has shown that eliminating cost-sharing for preventive services may be
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essential to increase their utilization to recommended levels (Solanki et al, 2000). Researchers who
estimated the direct and indirect effects of cost-sharing on pap smearing and mammography found
that it negatively impacted the receipt of preventive care, suggesting that cost-sharing elimination
increases preventive care service utilization (Solanki et al, 2000).
Past legislation has had similar goals as the ACA, aiming to make health care more
accessible and more affordable. Many of these reforms were successful in improving preventive
care utilization. An important example comes from the state of Massachusetts that expanded to a
near-universal health insurance coverage in 2006. A study comparing the effects of the
Massachusetts reform on mammograms and pap smear tests between 2002 and 2010 found a
significant increase in their utilization, especially among low-income women (Sabik and Bradley,
2016). Goodwin and Anderson found that after the 1997 elimination of cost-sharing legislation,
which provided a deductible waiver for Medicare beneficiaries, pap smear tests and mammograms
significantly increased in their utilization (Goodwin and Anderson, 2012). Another study
examining the effect of a provision under the 2003 Medicare Prescription Drug, Improvement, and
Modernization Act, that expanded the coverage of preventive services, reported an increase in
utilization of mammograms and pap smear tests, especially among individuals with lower
deductible plans (Meeker et al., 2011). The success from previous reforms indicate that there is a
high potential for the ACA to reach its intended outcomes, especially in cancer preventive care,
over a long period of time.
Research has consistently shown that cost-sharing in all forms creates a financial barrier
on individuals and reduces the utilization of preventive services and (Rubin and Mendelson, 1995).
Therefore, in an effort to increase access and control costs, in 2010, the ACA mandated that private
health plans should cover forty-five specific recommended preventive services and eliminate all
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forms of cost-sharing such as copayments, deductibles and co-insurance. Since out-of-pockets
payments are identified as a barrier to utilize preventive care services among both insured and
uninsured individuals, they were eliminated under this provision to enhance access to preventive
services, including breast, cervical and CRC cancer screenings.
The screening guidelines and recommendations for the recommended preventive services
come from public medical and scientific organizations including the U.S. Preventive Services Task
Force (USPSTF) and the Advisory Committee on Immunization Practices (ACIP). The USPSTF
is volunteer panel of independent national experts who develops specific recommendations for
clinical preventive services to the health care system in the US based on the most up-to-date
scientific evidence. The USPSTF provides primary and secondary prevention recommendations
that aim to monitor clinical and preventive care and are adopted by several federal and private
groups as they are widely considered the best resource for preventive services management (Moyer
et al., 2011; USPSTF, 2013). The USPSTF assigns a letter grade for each recommendation (an A,
B, C, or D grade or an I statement; describe below) based on the strength of the scientific evidence
supporting its benefits. The grade assigned to a service does not relate to the cost of that service.
Along with the USPSTF recommendations, the ACIP provides recommendations that perform as
a standard to guide safe use of vaccines among children and adults. The ACIP is a group of medical
and public health experts who develops evidence based recommendations and standards of
vaccinations among the US population.
Precisely, the ACA cost-sharing elimination provision mandates that health coverage plans
eliminate cost-sharing of all forms for preventive services recommended by the USPSTF that have
a rating of A or B (Shearer, 2010). These are new requirements specified by the ACA, as formerly
private coverage plans were not required to comprehensively pay for an authorized group of
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preventive services. For more information about the grades definitions from the USPTSF, refer to
Table 2.
Table 2. USPSTF Ratings: What the Grades Mean and Suggestions for Practice
Grade

Definition

Suggestions for Practice

A

The USPSTF recommends the service.
There is high certainty that the net benefit
is substantial.

Offer or provide this service.

B

The USPSTF recommends the service.
There is high certainty that the net benefit
is moderate or there is moderate certainty
that the net benefit is moderate to
substantial.

Offer or provide this service.

C

Clinicians may provide this service to
selected patients depending on individual
circumstances. However, for most
individuals without signs or symptoms
there is likely to be only a small benefit
from this service.

Offer or provide this service only if
other considerations support the
offering or providing the service in an
individual patient.

D

The USPSTF recommends against the
service. There is moderate or high
certainty that the service has no net
benefit or that the harms outweigh the
benefits.

Discourage the use of this service.

I
The USPSTF concludes that the current
Statement evidence is insufficient to assess the
balance of benefits and harms of the
service. Evidence is lacking, of poor
quality, or conflicting, and the balance of
benefits and harms cannot be determined.

Read the clinical considerations
section of USPSTF Recommendation
Statement. If the service is offered,
patients should understand the
uncertainty about the balance of
benefits and harms.

Source: U.S. Preventive Services Task Force Ratings. U.S. Preventive Services Task Force. December 2013.
https://www.uspreventiveservicestaskforce.org/Page/Name/us-preventive-services-task-force-ratings

The ACA cost-sharing elimination requirement was extended to all new and renewed
private health plans after September 23, 2010. Private health plans must be individual plans, small
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and large business plans, and self-insured plans. However, the provision did not apply to
grandfathered plans, which are private coverage plans that were created or acquired before March
23, 2010. Cost-sharing was later eliminated for Medicare beneficiaries on January 1, 2011 (Koh
and Sebelius, 2010) (Centers for Medicare & Medicaid Services). The aim for eliminating these
costs was to improve utilization of preventive services by eliminating cost barriers that inhibit
individuals from obtaining preventive services and thus increase access to eventually improve
population health. For more information about the specifics of this provision for private coverage
plans, refer to the Table 3 below, which was adapted from the U.S. Department of Health and
Human Services (Health Policy Brief, Health Affairs, 2010).

Table 3. Preventive Services Required of New Group & Individual Health Plans Without
Cost Sharing
Evidence-based preventive services

Preventive services recommended by the
U.S. Preventive Services Task Force based
on the strength of the scientific evidence
documenting their benefits. Includes breast
and colon cancer screenings, screening for
vitamin deficiencies during pregnancy,
diabetes, high cholesterol, high blood
pressure, and tobacco cessation counseling

Routine vaccinations

Sets of standard vaccines recommended by
the Advisory Committee on Immunization
Practices, ranging from routine childhood
immunizations to periodic tetanus shots for
adults

Preventive services for children

Preventive services recommended under the
Bright Futures guidelines developed by the
Health Resources and Services
Administration and the American Academy
of Pediatrics for children from birth to age
21. Includes regular pediatrician visits, vision
and hearing screening, developmental
assessments, immunizations, and screening
and counseling to address obesity
20

Preventive services for women

Will also include services recommended
under new guidelines expected to be issued
by August 2011, in addition to services
recommended by the Preventive Services
Task Force

Source: Cassidy, Amanda. “Health Policy Brief: Preventive Services Without Cost Sharing.” Robert Wood
Johnson Foundation Health Policy Brief Series. Health Affairs, December 28, 2010.

The Impact of the ACA on Preventive Care Services Utilization
Shortly after the implementation of the ACA cost-sharing elimination provision for
preventive services, many researchers examined the impact on the prevalence of the preventive
services that were covered. Some researchers examined a package of these services, while some
only examined specific illness related screenings, such as cancer screening tests and cardiovascular
related screening tests. Many studies found significant increases in the utilization of preventive
services indicating a positive effect of the provision. A study conducted to examine the effects of
the ACA provision on the receipt of preventive care among young adults between 2009 and 2011
found a significant increase in the receipt of preventive services, particularly in routine
examination, blood pressure screening, cholesterol screening and the annual dental visit (Lau et
al, 2014). Using a time series data method, an analysis of mammography utilization that examined
patient level data from a large community-based health system from 2008 to 2012 showed that
mammography usage increased significantly among women who were form the recommended age
group of 50 to 74 (Nelson, 2015). A more recent study that was conducted to measure the impact
of the ACA elimination of out-of-pocket payments on mammography and colonoscopy among
Medicare beneficiaries between 2009/2010 and 2011/2012 found a significant increase in
mammography utilization but not in colonoscopy (Cooper et al, 2016). Using the National Health
Interview Survey data, an analysis of mammography utilization between 2010 and 2013 among
21

Medicare beneficiaries showed a modest increase (Sabatino, et al, 2016). A following study
examining mammography rates between 2007 and 2012 among Medicare women, who were part
of a large Medicare advantage health plan, found a slight increase in mammography utilization
among women with no previous screenings (Jena et al, 2017). The previous studies suggest
positive gains from the ACA cost-sharing elimination provision, however, the literature was mixed
with different observations of the ACA effect.
There were other studies that found very little impact of the provision on cancer preventive
screenings, or the impact being more prevalent in specific underprivileged groups including the
poor and the elderly. For example, Fedewa and colleagues examined the utilization of
mammography and CRC cancer screenings, (colonoscopy, FOBT, and sigmoidoscopy), between
2008 and 2013, among privately and Medicare insured individuals. The results showed a
significant increase in CRC screenings among individuals with low socio-economic status or who
were older. However, no change was found in the utilization of mammography (Fedewa et al,
2015). A similar study conducted to evaluate whether the ACA provision has resulted in an
increased use of CRC cancer screenings found no significant change, however, colonoscopy
utilization increased among Medicare beneficiaries who were poor and without additional
Medicare coverage (Richman et al, 2016). Similarly, a study examining colonoscopy utilization
among Medicare elderly men found a significant increase in utilization of colonoscopy, especially
among the group of men who were from a lower socio-economic status, on the other hand, there
was no significant change among elderly women that was explained to be related to other
behavioral factors (Hamman and Kapinos, 2015). In a pre/post analysis using administrative date
for Medicare beneficiaries from rural health clinics, increases in CRC cancer screening rates were
observed (Wan et al, 2015). In the following section, we will discuss the observations of some
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evidence based research that showed a null or negative impact of the ACA cost-sharing elimination
provision for preventive care services.
There were several studies that found no evidence of a positive effect related to the ACA
provision. Mehta and colleagues examined the impact of the ACA provision on colonoscopy and
mammography, between 2008 and 2012, among an insured small business population
(HUMANA) and found no significant change in utilization of both cancer screenings (Mehta et al,
2015). However, the study concluded that the null findings might be due to the short period after
the policy implementation, which might have not been enough to allow for the intended results to
appear (Mehta et al, 2015). Han and colleagues evaluated changes in the utilization of cervical,
breast, and CRC cancer screenings, between 2009 and 2012 among the privately and Medicare
insured individuals, and found no change in utilization after controlling for demographic variables,
confounding variables, and stratification by insurance type (Han et al, 2015). Similarly, a study
that evaluated the effects of the provision on mammography and CRC cancer screenings among
Medicare seniors between 2008/2010 and 2012 found no change in utilization even among
Medicare seniors without supplemental insurance (Jensen et al, 2015). A more recent study
evaluating the impact of the provision among the privately insured found that changes in the
utilization of mammograms, pap smears, and CRC cancer screenings were not a result of the ACA
(Hong et al, 2017). The findings of these studies were not consistent with earlier ones. Studies with
null findings attributed their results to several factors including the lack of data for long periods of
time after the ACA (Jensen et al, 2015).
Utilization of Preventive Services Among Low-income Patients
Utilization of health services, in general, is more likely to differ among low-income
patients as a result to changes in cost-sharing (Baicker and Goldman, 2011). In the RAND Health
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Insurance Experiment (HIE), which examined the association between demand and behavior, lowincome individuals who were sick had more adverse health outcomes attributable to increased
cost-sharing. High mortality rates were higher for poor patients with low blood pressure when they
had higher copayments (Manning et al, 1987). Another study reported that low-income individuals
made fewer well-informed decisions because of poor communication skills between patients and
physicians due to a positive correlation between education and income (Reeder and Nelson, 1985).
In their study of health outcomes by socio-economic status (SES), Goldman and Smith showed
that individuals with lower socio-economic status tend to have worse health outcomes because
they are less likely to adhere to the treatment of their chronic conditions (Golden and Smith, 2002).
From an economics perspective, Chandra and colleagues mentioned three reasons that
explain why low-income patients have differential effects. Based on their study, low-income
individuals are more impacted by price because of their restricted budgets, indicating that they are
expected to obtain less care with the lowest marginal benefit (Chandra et al, 2014). Secondly, lowincome individuals were less likely to evaluate the benefit of their care than individuals with high
income and, accordingly they are more prone to obtain less high marginal benefit care. Third, it
was suggested that the effect of cost-sharing could be different for low-income individuals because
they tend to have more chronic conditions (Chandra et al, 2014).
From the existing evidence, it is established that cost-sharing may result in a judicious
utilization of health care services. Financial requirements tend to reduce the use of valuable care,
especially for vulnerable groups such as low-income individuals (Chernew et al, 2007). Hence, it
is imperative to understand the impact of cost-sharing on the use of specific preventive services
that are identified as methods to improve health, especially amongst low-income individuals, who
are more prone to adverse health effects because their sensitivity to price that leads lower health
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care use (Manning et al, 1987). Baicker and Goldman suggested that there is little evidence that
poor individuals have more elastic demand despite the high speculation in the research community
(Baicker and Goldman, 2011). They commented that most of the conducted research concentrates
on the impact of copayments for prescription medication under Medicaid (Stuart and Zacker, 1999;
Reeder and Nelson, 1985).
Although previous studies have established that cost-sharing elimination could potentially
increase preventive health services utilization, many of these studies have not investigated socioeconomic and socio-demographic factors related to preventive services usage. The effect of costsharing elimination on preventive service utilization among individuals with low socioeconomic
status is limited (Han et al, 2015). To date, only a few studies evaluated the effects of cost-sharing
on use of cancer preventive services in national samples that represent the population
(Rezayatmand et al, 2013).
This study utilized a national sample from the MEPS, which has been extensively used in
the literature for analysis to draw conclusions that are representative of the national population in
the US. Furthermore, the inconsistency of previous research evaluating the ACA cost-sharing
provision could be due to the lack of long periods of time at the time of analysis. The data available
for preceding analysis was appropriate to assess short-term effects of the provision. Most of the
studies mentioned in the literature review analyzed data until 2012. In this study, more up-to-date
data, that was available until 2016, allowed assessment of the long-term effects of the provision.
In additional, studies lacked methodological approaches that could draw solid conclusions. One
example of these approaches is to compare changes in the utilization of services to a control group
which can produce robust conclusions in regards to causality. A recent study examining cancer
diagnosis among Medicare beneficiaries found a significant increase in early stage CRC cancer
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diagnosis compared to a younger control group, without evidence of change in breast cancer
diagnosis (Lissenden and Yao, 2017). Therefore, this study utilized the DID approach that allowed
for comparison of utilization rates in the treatment group (the insured) to a control group (the
uninsured) after validating the required assumptions of the DID approach. This study makes a
significant contribution for policy makers and researchers about the effectiveness of cost related
policies that could eventually help to increase access to cancer preventive screenings throughout
the US.

Breast, Cervical and Colorectal Cancer Screening Rates
A main goal of the Healthy People 2020 is to: “reduce the number of new cancer cases, as
well as the illness, disability, and death caused by cancer.” Apparently, Healthy People 2020 aims
is to increase screening for breast, cervical, and CRC cancer as recommended by USPSTF (Office
of Disease Prevention and Health Promotion, 2017). One way to achieve this goal is to compare
current rates of screenings with established nationwide targets. An analysis utilizing the 2015
National Health Interview Survey (NHIS) data, tested trends from 2000 to 2015 and found that
usage of certain cancer screening tests was significantly below the ideal national targets. These
national targets were implemented by Health People 2020, which provides national goals to
improve the health of Americans. The analysis found no increases for breast and cervical cancer
screenings; however, CRC cancer screenings increased. Differences were found in utilization rates
among individuals with different races and different socioeconomic backgrounds.
According to the Centers for Disease Control and Prevention (CDC), mammography usage
was steady from 2000 to 2015. Mammography usage rate was found to be 71.5% during the last
two years in 2015 for women aged 50 to 74. This rate remains below the national target of 81.1%.

26

Receiving a mammogram was lowest among American Indians/Alaska Natives with a rate of
56.7%. The results indicated that women who were educated and had a higher-income level
received more mammograms. Women who were uninsured and who did not have a continuous
source of health care reported the lowest mammography rates (White et al, 2015). Cervical cancer
screening, particularly the pap smear test, declined from 2000 to 2015. In 2015, only 83% of
women had cervical cancer screening. This rate remains beneath the Healthy People 2020
established target of 93.0%. The pap test utilization was the lowest among Asian women with a
rate of 75.8%. Also, women of the age group between 21 and 30 years old had lowest cervical
cancer screening usage. Like mammography, the results indicated that women who were educated
and had a higher-income level received more cervical cancer screenings. Furthermore, women
who were uninsured and who did not have a continuous source of health care reported the lowest
cervical cancer screening rates (White et al, 2015).
CRC cancer screening increased from 2000 to 2015 to 62.4%; however, the rate remains
beneath the Healthy People 2020 established target of 70.5%. CRC screening use was lowest
among American Indians/Alaska Natives with a rate of 48.4%. Also, CRC screening was lower
among individuals aged 50–64 years than among individuals aged 65–75 years even though the
guidelines recommend screening starting at age 50. Moreover, the percentage of individuals who
reported having a CRC cancer screening increased with increasing education and income levels.
Moreover, individuals who were uninsured and who did not have a continuous source of health
care reported the lowest CRC screening rates (White et al, 2015).
Despite forceful determination to increase mammography, cervical, and CRC cancer
screenings during the last few years, test screenings proportions remain substandard. As mentioned
earlier, one of the ACA goals is to increase the rates of screenings through total coverage of these
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screening tests without any cost-sharing incurred by the patient. One of the strategies shown to
increase utilization of preventive services is removing cost barriers that are incurred by patients to
receive these services. Patients with private insurance and Medicare were responsible to bear some
costs to their CRC screening services before the ACA through co-insurance, copayment, and
deductibles. This cost responsibility created a burden on patients, especially with expensive
procedures such as colonoscopy and sigmoidoscopy. The cost of cancer screening tests is usually
very high. For example, Medicare charged patients in 2008 for mammograms between $82 and
$115. Also, the permissible charge for patients under Medicaid was between $642 and $842 for
colonoscopy in 2008. Medicare patients had a permissible charge for colonoscopy that ranged
between $642 to $842 before the ACA (Fedewa et al, 2015). Furthermore, Medicaid patients had
a permissible charge that ranged between $130 to $200 for sigmoidoscopy (Cokkinides et al,
2011). Therefore, identifying whether the cost-sharing elimination provision changed the
utilization of breast, cervical, and CRC cancer screening is important to understand if it had the
policy desired effects and if financial barriers are the main reason for suboptimal screening rates.
PUBLIC HEALTH SIGNIFICANCE
One of the central reasons of the ACA cost-sharing elimination provision is to promote
awareness about the importance and effectiveness of preventive services in improving an
individual’s quality of life, wellness, and health outcomes. One of the primary long-term public
health goals of the US health care system is to have better preventive care services that will
eventually lead to improving population health and reduce health-related spending. This goal could
be achieved by formulating and implementing policies that ensure continuous screenings and
management of chronic conditions; by promoting access to preventive health services in removing
financial barriers; and by monitoring the accessibility and quality of care.
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Preventive care screening services for breast, cervical, and CRC cancer are imperative
since they have a high capability to lessen the burden of cancer in the United States (Maciosek et
al, 2009). Despite the significant efforts that have been made to increase cancer screenings,
screening rates for breast, cervical, and CRC cancer remain suboptimal and disappointingly low
(Office of Disease Prevention and Health Promotion, 2017). The monetary costs of cancer are high
for both the individual with cancer and for the society as a whole. The Agency for Healthcare
Research and Quality (AHRQ) estimates that the direct medical costs for cancer in the US in 2015
were $80.2 billion. This year, around 609,640 Americans are predicted to die from cancer which
is approximately 1,670 persons a day (American Cancer Society, 2018). After heart disorders,
cancer is the second most common cause of death in the US. The implementation of the costsharing elimination provision will help address this through the elimination of financial barriers
that prevent individuals from getting the screenings.
The main goals of public health are to promote and protect health, prevent death and
injuries, and prolong lives (Munthe et al, 2008). The implementation of the ACA is a powerful
step that could eventually help to achieve the three goals of public health by removing financial
barriers and promoting access to preventive care. This dissertation will help to evaluate the effect
of the recent cost-sharing elimination provision under the ACA on cancer screenings rates and
disparities among different groups, which would provide information to policy makers and health
professionals on whether the cost-sharing elimination provision produced the intended results. If
that was not the case, other reasons for suboptimal cancer screening rates could be evaluated. It is
evident that better health coverage and enhanced access are essential; however, they could not be
adequate to achieve optimal utilization of preventive care services.
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AIMS AND OBJECTIVES
This study investigated the impact of the ACA cost-sharing elimination provision on the
utilization of three cancer prevention screenings. Specifically, the current study evaluated changes
in breast, cervical, and CRC cancer screening utilization, among individuals who were privately
insured and/or Medicare-insured, before and after the cost-sharing elimination provision was
enacted. This provision became effective for private health insurance plans, in 2010, and for
Medicare, in 2011. A focus of this dissertation was on the influence of socio-economic and sociodemographic factors on utilization changes. This study utilized the national Medical Expenditure
Panel Survey (MEPS) data, from 2008 through 2016, for the analyses. The results of this
dissertation expanded the current knowledge of the impact of the ACA cost-sharing elimination
provision in increasing utilization of five imperative cancer screening services including
mammography, pap smear, FOBT, colonoscopy and sigmoidoscopy.
Aims
Aim 1: To evaluate changes in receipt of breast cancer (i.e. mammography) and cervical
cancer screening (i.e. pap smear) services pre-and post implementation of the ACA costsharing elimination provision, from 2008 through 2016, using MEPS.
•

Objective 1: To determine whether the utilization of mammography and the pap smear test
increased after the implementation of the cost-sharing elimination provision among private
and/or Medicare-insured women in the United States.

•

Objective 2: To examine whether differences in medical utilization of mammography and
the pap smear test result from differences in socio-economic and socio-demographic
factors, as measured by predisposing, enabling and need predictors of resource use.
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Aim 2: To evaluate changes in receipt of colorectal cancer (CRC) screening services pre-and
post implementation of the ACA cost-sharing elimination provision, from 2008 through 2016
using MEPS.
•

Objective 1: To determine whether the utilization of CRC cancer screening increased after
the implementation of the cost-sharing elimination provision among private and/or
Medicare-insured individuals in the United States.

•

Objective 2: To examine whether differences in medical utilization of CRC cancer
screening services result from differences in socio-economic and socio-demographic
factors, as measured by predisposing, enabling and need predictors of resource use.

CONCEPTUAL FRAMEWORK
The Health Behavior Model, or widely known as the Andersen’s Behavioral Model of
Health Services Use (BM), will be applied to examine the relationship between preventive services
utilization and cost-sharing elimination with the focus on specific socioeconomic factors
(Andersen et al, 2001). The BM was selected to guide independent variables selection for our
analysis since it is a well-established model used in studies that investigate health care services
utilization. It is a multilevel model that includes determinants of health services utilization at
individual and contextual levels. The BM was developed by Ronal M. Andersen, Aday and others
in 1968 and it explains the effect of the predisposing, enabling, and need factors on patient
utilization of health care services (Andersen, 1995). The model will help to understand the factors
that affect health utilization and is useful to assess the reasons for differences in utilization by
socio-economic and socio-demographic factors.
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For the study purposes, health behavior is identified as the utilization of preventive care
services. Figure 1 represents the schematic view of our research model highlighting the dependent
variable (health behavior), all explanatory variables, and control variables. The figure illustrates
the BM model and the means in which the predisposing, enabling, and need factors impact health
services utilization.
Next, the study explores the socio-economic and socio-demographic factors, deriving
evidence from prior research conducted about utilization of preventive services and based on the
work of Andersen & Davidson about these factors (Andersen and Davidson, 2001). Each of the
aims of this dissertation will utilize the BM Model as the foundation to identify the factors that
explain the use of cancer screening services, specifically, breast, cervical and CRC cancer
screenings.
Predisposing factors
According to the BM model, predisposing factors comprise the factors that influence
individuals to use health services including demographic characteristics such as age and sex, social
factors such as education, employment, race, ethnicity, social relationships, health beliefs, and
socio-economic characteristics. Socio-economic characteristics tend to have an influence on
healthcare utilization in general. For example, patients of lower socioeconomic status have higher
rates of chronic conditions, which implies a differential effect of cost-sharing policies on their
utilization of services. Moreover, patients with low socioeconomic status were found to be less
adherent to treatment protocols for their chronic conditions and thus have worse health outcomes
(Goldman and Smith, 2002).
The literature usually measures socioeconomic disparities by income, education, and
occupation. It is apparent that individuals with higher income, education, and better occupations
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would have more access to resources that are connected to being healthier, such as healthcare
services, healthier lifestyles, nutritious behaviors, and others (Zimmerman, Woolf & Haley, 2014).
The cost-sharing provision is expected to reduce the socioeconomic disparities in health across
those individuals.
There are disparities by race and socioeconomic factors that were documented in the
literature in regards to utilization of preventive services. These disparities indicate that minorities,
such as Hispanics and blacks were, in general, less likely than whites to receive preventive services
such as cholesterol screening, blood pressure checks, and cancer screenings (Gornick, 2000).
White women received more cervical and breast cancer screening services compared to women
from other races including black Americans (Nadpara et al, 2012; Bhanegaonkar et al, 2012).
Another study reported contradictory findings indicating that minority women in specific
communities were more likely to receive cervical and breast cancer screenings (Cook et al., 2010;
Coronado, Thompson, and Chen, 2009). Moreover, there were disparities by age that were
documented in the literature. For example, it has been reported that age is negatively associated
with mammograms and positively associated with pap smears, cholesterol, and blood pressure
screenings (Holden, Chen and Dagher, 2015).
Education is also a factor that could impact preventive care service utilization. In a study
of medication copayments under Medicaid, low-income individuals were found to make fewer
well-informed decisions because of their poor communication skills with their physicians as a
result of a positive correlation between education and income (Reeder and Nelson, 1985). Higher
levels of education are associated with greater utilization of preventive health care services
(Hewitt, Devesa and Breen, 2002).
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Enabling/Impeding factors
In general, enabling/impeding factors are the resources available to individuals to utilize
health services such as income, health insurance, and continuity of care. Enabling factors are also
defined as the financing and organizational factors that enable conditions that influence health care
utilization. The financing factors are specifically related to the income level of individuals that
allow them to pay for health services. These factors are associated with health insurance coverage
and cost-sharing requirements. Organizational factors involve the sources and continuity of care.
Chandra et al, (2014) argued that cost-sharing could have a different impact on low-income
patients who sometimes tend to avoid care with the lowest marginal benefit because of their
financial constraints. Several other studies showed that having a higher income is associated with
increased preventive service use (Chernew et al, 2007). For example, out-of-pocket payments can
enable or impede the use of health services depending on their amounts. Cost-sharing has been
reported as an impediment to receive preventive services and thus removing this barrier is
important to increase utilization (Solanki et al, 2000). Further, in a study about the utilization of
preventive services recommended by the USPSTF, receipt of services was strongly positively
associated with having insurance coverage and a constant source of care (DeVoe et al, 2003).
Several studies also determined this positive association (Bednarek & Schone, 2003; Bandi et al,
2012; Allen et al, 2009).
Need factors
Need factors include individuals perceived need for health services such as their functional
status, previous conditions, or health risks. Need factors include perceived or evaluated health
complications that either patients or health care providers decide that they need medical service
intervention (Andersen, 1995). Several studies showed that having certain risk factors could
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increase the probability of using some preventive services. For example, a study reported that
overweight and obese men received more cholesterol and glucose screening but less CRC cancer
screenings or prostate cancers screenings (Quinn et al, 2012). Another study found that an
increasing body mass index (BMI) was associated with increased utilization of preventive services
(Shires et al, 2012).
Although it might be projected that individuals with more risk factors are more likely to
seek certain preventive services, several studies showed that individuals who have asthma and who
are smokers were significantly less likely to receive an influenza vaccine despite their risky
situations (Lu et al, 2009; Vander et al, 2012). Despite their increased risk of cancer, daily smokers
were found to be less likely to receive cancer screening (Vander et al, 2012). Patients of lower
socioeconomic status have higher rates of chronic conditions, which imply differential effect of
cost-sharing policies on their utilization of services. A study examining the relationship between
the and being up-to-date on cancer screenings found an increase in screenings with specific types
of chronic conditions rather than the total number of conditions (Liu et al, 2014). Contrariwise,
several studies have found that the number of chronic diseases is correlated with increased cancer
screenings. For example, hypertensive individuals had more breast exams, pap smears, FOBTs,
and a trend to have more mammograms (Heflin et al, 2002). Also, women with three or more
chronic conditions were shown to have more mammograms, pap smears, and breast exams
(Yasmeen et al, 2011; Zao et al, 2008).
In summary, prior studies have shown conflictive results for the impact of predisposing,
need, and enabling factors on cancer preventive care usage. Therefore, to have more robust
evidence, this study focuses on the inclusion of socio-demographic and socio-economic factors
that had some evidence to impact utilization. By including all these factors, as covariates, in the
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DID the model, they will provide more precise information about the change in the main outcomes
of cancer screenings.
Figure 1. Study Model
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METHODS
Data Source
This study utilized the Medical Expenditure Panel Survey (MEPS), which is a part of the
US Department of Health and Human Services data that includes national and regional estimates
of numerous aspects of healthcare. The MEPS is a nationally representative survey of noninstitutionalized US individuals, their families, and their medical providers (physicians, hospitals,
pharmacies, etc.), which is sponsored by the Agency for Healthcare Research and Quality
(AHRQ). The MEPS has three main components: the primary Household Component, the
Insurance/Employer Component, and the Medical Provider Component. This study utilized the
Household Component that is publicly available (AHRQ, 2016). More information about the
MEPS survey design and content is available from the MEPS website (AHRQ, 2016).
The MEPS is widely used by prominent medical researchers, as well as the government, to
evaluate the health care system. One of the most important advantages of the MEPS survey is that
it is done on a constant basis which delivers researchers with useful and timely information. The
MEPS was created in 1996 to provide more opportune information about the developing health
care system in the US. The MEPS initiates a new panel of households into the survey each year.
The MEPS has a panel design that includes five series of interviews covering two full years. It
collects data on the usage of health services, their costs, the ways these services are paid for, and
health insurance coverage. It provides data, at the individual participant level, on the socioeconomic and socio-demographic characteristics of survey participants (Ezatti-Rice, Rohde, and
Greenblatt, 2008). The data is conveyed by a particular household respondent. Respondents
answer questions over five interviews during a two-and-a-half-year period. Questions in the
Household component include demographic characteristics, health conditions, health status,
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utilization of medical care, charges and payments, access to care, insurance coverage, income,
education and employment (Cohen et al, 2009).
The MEPS Household Component collects information about health insurance coverage
by person and family-level characteristics. The MEPS contains a constructed variable that
summarizes health insurance coverage for any individual with three different values: 1= any
private (having any type of private insurance (including TRICARE/CHAMPVA), 2= public
insurance, 3= uninsured. There are other insurance coverage variables that indicate the type of
public health coverage that an individual has. For this study sample, all individuals with
Medicaid coverage were excluded from the sample. Only individuals with private and/or with
Medicare coverage were included in the study sample. The MEPS categorizes TRICARE as
private coverage. In this study, TRICARE was categorized as a type of private coverage,
similarly as in the MEPS data.
This study analyzed nine years of pooled MEPS data (2008 through 2016) and examined
changes in the use of five cancer preventive screening services including mammography, pap
smear, FOBT, colonoscopy and sigmoidoscopy, before and after the implementation of the ACA
cost-sharing elimination provision, focusing on the effect of specific socio-demographic and socioeconomic factors. The analysis was conducted in 2019.
Study Design
A quasi experimental difference-in-differences (DID) approach was used to estimate the
effect of the ACA cost-sharing elimination provision on cancer preventive services by comparing
the changes of breast, cervical and CRC cancer screening rates between individuals who benefitted
from this provision (the insured) and individuals who did not (the uninsured). The DID approach
has become an increasingly prevalent method to estimate causal relationships and it is used to
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estimate the effect of a specific intervention (such as an enactment of a law, or a program
implementation), by comparing the changes in outcomes over time between a population that is
enrolled in a program (the intervention group) and a population that is not (the control group)
(Dimick & Ryan, 2014).
DID is normally utilized in observational settings and it assumes that in absence of
treatment, the unobserved differences between treatment and control groups are the same overtime
(Dimick & Ryan, 2014). DID requires data from pre/post intervention period for both the treatment
and control groups; it is a valuable method to use when randomization on the individual level is
not possible (Wing et al, 2018). The DID technique calculates the effect of a treatment
(independent variable) on an outcome (dependent variable) by comparing the average change over
time in the outcome variable for the treatment group, compared to the average change over time
for the control group (Dimick & Ryan, 2014). Thus, the DID technique was the best approach to
improve the internal validity of our analysis and to account for possible secular trends.
One of the most important assumptions in the DID methodology is that trends in the
outcomes before the intervention are parallel across the treatment and control groups (Wing et al,
2018). That means, in the nonexistence of the policy, the two groups would have continued to
change with matching trends (Angrist & Pischke, 2009). For this study, the parallel trend
assumption between insured (treatment) and uninsured individuals (control) was not violated for
any of the cancer screening services examined (Figures 2, 3, 4, 5, and 6).
For this study, the DID approach was applied to the regression estimations by comparing
results before and after the introduction of the independent variable in 2010, which is the ACA
cost sharing-elimination provision for preventive care services, between insured and uninsured
individuals. The USPSTF recommendations for the selected cancer preventive services were
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adopted to measure odds of receipt by socio-demographic and socio-economic factors. The
primary dependent variable and covariates representing the socio-demographic and socioeconomic factors are discussed in the section below.
Study Measures
Primary Dependent Variables
The primary dependent variable for each logistic regression model is self-reported receipt
of the cancer screening service. Five preventive cancer screenings were analyzed, including
mammography for breast cancer screening, the pap smear for cervical cancer screening, FOBT,
colonoscopy and sigmoidoscopy for CRC cancer screening. Receipt of each screening is defined
as having the screening service within the interval period and age requirements set by the USPSTF
guidelines.
In the MEPS survey, respondents were asked about the last time they received a screening
test. The respondents had to choose an answer from a few given options including if they have
received the screening test during the last year, two years, etc. Receipt of each cancer screening
service had a binary outcome of (yes, no). Table 4 summarizes the examined cancer screening
services by the recommended population, frequency of assessment, and the MEPS survey
questions.
Table 4. Breast, Cervical, and CRC screening services recommended population,
frequency of assessment, and the MEPS survey questions.
Screening
Breast Cancer
(Mammogram)
Cervical Cancer (Pap
Smear)
Colorectal Cancer
Fecal Occult Blood

Recommended
Population
Women aged 50-74

Frequency

Women aged 21-65

Every 3 years

Adults aged 50-75

FOBT yearly or,

Every 2 years
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MEPS Survey
Questions
How long since last
mammogram?
How long since last
pap smear test?
When was last
FOBT?

Test (FOBT)
Colonoscopy
Sigmoidoscopy

Colonoscopy every
10 years, or

When was last
colonoscopy?

Sigmoidoscopy
every 5 years with
FOBT every 3 years

When was last
sigmoidoscopy?

Source: US Preventive Services Task Force Website

Independent Variables
Primary Independent Variables
The primary independent variables are POST, INSURED, and POST*INSURED. The
variable POST is defined as the period after the implementation of the ACA provision (2008 to
2010 vs 2011 to 2016). The variable POST indicates whether the period is post or pre-ACA
intervention, which is a key variable in every DID estimation model. Including POST in the
equation manages the time trend problem and shows utilization differences among the uninsured
(the control group) after the ACA provision. The variable INSURED, which is considered as an
enabling factor, is a dummy variable that shows the differences between the treatment (insured
individuals) and control (uninsured individuals) groups in the pre-period. Finally, the variable
POST*INSURED is an interaction term that provides the actual estimated effect of the policy
intervention. It is the difference in the treatment group before and after ACA implementation
minus the difference in the control group before and after the ACA implementation. In other words,
the interaction of post and insurance shows how insured individuals changed their utilization of
the five examined cancer screenings after the ACA provision.
Covariates:
The choice of covariates, including other socio-demographic and socio-economic factors,
was guided by the BM model and the preceding literature related to cancer screening determinants.
Predisposing factors included age, gender (only for CRC cancer screening), race, ethnicity, marital
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status, education, and employment. Enabling factors included income, insurance status, regular
source of care, number of visits, region, and residence. Health needs factors included perceived
health status, number of chronic conditions, smoking status and body mass index (BMI).
Table 5 lists all the independent variables that were perceived to have an impact on the dependent
variables. The variables were categorized according to the BM model as predisposing, enabling,
and/or need factors.
Table 5. Independent Variables
Predisposing Factors
Independent
Variable

Definition

Measurement

Age

Person’s age

Continuous

Gender*

Person’s gender

Dichotomous,1=Female,
0=Male

Race

Person’s race

Categorical, 1=White,
2=Black, 3=American
Indian/Alaska native,
4=Asian, 5=Native
Hawaiian/Pacific islander,
6=Multiple races

Ethnicity

Person’s ethnicity

Dichotomous, 1=Hispanic,
0=Non-Hispanic

Marital Status

Patients’ marital status

Dichotomous, 1=Married,
0=Not married

Education

Person’s educational attainment

Ordinal, 1=Less than high
school, 2=High school,
3=Some college, 4=Four
year of college or more
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Employment

Person’s employment status

Continuous

Enabling Factors
Independent
Variable

Definition

Measurement

Income

Indicates person’s total Income

Continuous

Insured

Indicates whether a person is insured, or
uninsured

Dichotomous, 1=Insured,
0=Not Insured

Regular source
of care

Indicates whether there is a doctor’s
office, clinic, health center, or place that
the individual usually goes to if he/she
needs to

Dichotomous, 1=Yes, 2=No

No. of visits to
care

Indicates number of office based
provider visits

Numerical

Region

Indicates the Census region for the
person

Categorical, 1=Northeast,
2=Midwest, 3=South 4=West

Residence

Indicates whether the person is found in
a Metropolitan Statistical Area

Dichotomous, 1=MSA, 0=
non-MSA

Need Factors
Independent
Variable
Perceived Health
Status

Definition

Measurement

Person’s perceived health status

Ordinal, 1=Excellent,
2=Very good, 3=Good,
4=Fair, 5=Poor
An average of the results was
considered

Number of
chronic
conditions

Indicates whether a doctor or other
health professional ever told the person
they had high blood pressure, heart
disease (including coronary heart
disease, angina, myocardial infarction,
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Numerical

and other unspecified heart disease),
stroke, emphysema, high cholesterol,
cancer (including cancer type), diabetes,
arthritis, or asthma.
Smoking Status

Person’s smoking status

Dichotomous,
1=Yes, 2=No

BMI

Person’s Body Mass Index

Continuous

* The gender variable was only included for the second aim

ANALYSIS
To address both aims, the study sample was summarized and descriptive statistics were
computed (i.e. mean, standard deviation and/or proportion) on all predisposing, enabling, and need
variables (independent variables). In addition, to determine if there was a significant difference
between the means of the variables before and after the policy provision, two samples t-tests were
conducted (Table 8). T-tests were performed under the assumption that variables fit a normal
distribution. All the statistical analysis was conducted using STATA version 15. Approval for this
study was obtained from the Committee for the Protection of Human Subjects at the University of
Texas, Health Science Center at Houston.
Addressing Aim 1
Aim 1: To evaluate changes in receipt of breast (i.e. mammography) and/or cervical (i.e. pap
smear) cancer screening services pre-and post implementation of the ACA cost-sharing
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elimination provision, from 2008 through 2016, using MEPS.
•

Objective 1: To determine whether the utilization of mammography and/or pap smear
increased after the implementation of the cost-sharing elimination provision among private
and/or Medicare-insured women in the United States.

•

Objective 2: To examine whether differences in medical utilization of mammography
and/or pap smear result from differences in socio-economic and socio-demographic
factors, as measured by predisposing, enabling and need predictors of resource use.

Aim 1-Hypothesis
The utilization of mammography and/or pap smear increased after the implementation of
ACA cost-sharing elimination among privately and/or Medicare insured women in the US as
access to preventive care services increased under the ACA.
Aim 1-Sample
For mammography, the sample included women, aged 50 to 74 years, as per the 2009
USPSTF recommendations. For pap smear, the sample included women, aged 21 to 65 years, as
per the 2012 USPSTF recommendations. Both groups were included because the provision directly
applies to them. For the DID analysis, uninsured women with equivalent age groups for each
cancer screening were included as a control group because they were not impacted by the
provision. Women under Medicaid coverage were excluded since participating in Medicaid
expansion under the ACA was optional for states (Wilensky and Gray, 2013). Women with breast
and/or cervical cancer, had surgery, or were diagnosed with conditions related to breast and/or
cervical cancer were excluded from the sample. In addition, women were excluded if they had
missing responses for the required period. Table 6 lists specific guidelines, USPSTF
recommendation grades, and the study target population for both mammography and pap smear.
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Table 6. Specific Guidelines/Study Population for Mammography and Pap Smear
Preventive Service
(year)

Recommendation (grade)

Study Target
Population

Mammography
(2009)

The USPSTF recommends
mammography every two years
for women aged 50 to 74. (B)

Women aged
50-74 and not
diagnosed
with breast
cancer

Pap Smear (2012)

The USPSTF recommends
screening for cervical cancer in
women age 21 to 65 years with
cytology (Pap smear) every 3
years or, for women age 30 to
65 years who want to lengthen
the screening interval, screening
with a combination of cytology
and human papillomavirus
(HPV) testing every 5 years. (A)

Women aged
21-65, not
diagnosed
with cervical
cancer, and
who have a
cervix

Screening interval
Every 2 years
(Biennial)

Pap smear every 3
years or pap smear
and HPV testing
every 5 years

Source: US Preventive Services Task Force Website

Aim 1-Analysis
To address objective 1, a proportions test was conducted to illustrate the proportion of
women who received mammography and/or pap smear out of the number of women who were
recommended to receive mammography and/or pap smear, before and after the ACA provision. In
addition, to determine if there was a significant difference between the values before and after the
policy provision, two samples t-tests were conducted. Table 9 shows the results of proportions test.
Furthermore, a trend analysis was performed visualizing yearly rates of being up-to-date on
mammogram and/or pap smear before and after the ACA provision to observe if there are changes
overtime. Figure 2 and 3 demonstrate the change in mammography and pap smear utilization rates
before and after the ACA provision.
To address objective 2, logistic regression models were estimated to measure the receipt of
mammography and pap smear controlling for all the predisposing, enabling, and need variables
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that are listed in table 5. Estimates of the impact of the policy on mammography and pap smear
were estimated by fitting four logistic regression models for each screening service that
incorporated a DID estimator. The first model was an unadjusted model that only controlled for
insurance status and period of screening (whether it was pre-or post the ACA provision). The
second model was an adjusted model that controlled for predisposing variables including age, race,
ethnicity, marital status, education and employment. The third model was additionally adjusted by
controlling for enabling factors including income, regular source of care, number of visits to care,
region and residence. The fourth and final regression model was further adjusted by controlling
for need factors including perceived health status, number of chronic conditions, smoking status,
and BMI. In order to select the model with the best possible fit, AIC values were generated to
show the quality of each model. The fourth model including all variables had the lowest AIC,
indicating the best fit for the logistic regression estimation. The regression models estimated the
odds ratios for all the independent variables and the corresponding 95% confidence intervals. The
regression analysis tested all women who had at least one recommended mammography or pap
smear against the independent variables that could have an influence on a women’s decision to
obtain the screenings. The primary variable of interest was the interaction term between the time
variable POST and the treatment group variable, INSURED. The first DID model examined the
receipt of mammography. The second DID model examined the receipt of pap smear.
Aim 1-Model Specifications
Model Specification 1 (for mammography):
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε
For the model estimated in this analysis, the DID estimation is explained by Y, which is the
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outcome of interest being the utilization rate of mammography, INSURED is a dummy variable
equal to 1 when women were insured and 0 when women were uninsured, POST is a time dummy
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables.
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the
control group. It is equal to the difference in utilization among the uninsured (the control group)
after the ACA provision. The coefficient β2 is the difference between the control and treatment
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of
interest β3 which is the difference in differences term. It represents the difference of changes over
time. β3 is the DID estimator that measures the effect of the policy intervention on insured women.
Finally, the coefficient βn represents how Y changes when a single covariate changes holding other
variables in the model constant.
Model Specification 2 (for the pap smear test):
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε
For the model estimated in this analysis, the DID estimation is explained by Y, which is the
outcome of interest being the utilization rate of pap smear, INSURED is a dummy variable equal
to 1 when women were insured and 0 when women were uninsured, POST is a time dummy
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables.
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control
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group, when all control variables are equal to zero. The coefficient β1 is the time trend in the
control group. It is equal to the difference in utilization among the uninsured (the control group)
after the ACA provision. The coefficient β2 is the difference between the control and treatment
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of
interest β3 which is the difference in differences term. It represents the difference of changes over
time. β3 is the DID estimator that measures the effect of the policy intervention on insured women.
Finally, the coefficient βn represents how Y changes when a single covariate changes holding other
variables in the model constant.
Addressing Aim 2
Aim 2: To evaluate changes in receipt of colorectal cancer (CRC) screening services pre-and
post implementation of the ACA cost-sharing elimination provision, from 2008 through 2016
using MEPS.
•

Objective 1: To determine whether the utilization of CRC cancer screening increased after
the implementation of the cost-sharing elimination provision among private and/or
Medicare-insured individuals in the United States.

•

Objective 2: To examine whether differences in medical utilization of CRC cancer
screening services result from differences in socio-economic and socio-demographic
factors, as measured by predisposing, enabling and need predictors of resource use

Aim 2-Hypothesis
The utilization of CRC cancer screening tests including FOBT, colonoscopy and
sigmoidoscopy, increased after the implementation of ACA cost-sharing elimination among
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privately and/or Medicare insured individuals in the US as access to preventive care services
increased under the ACA.
Aim 2-Sample
For CRC cancer screenings, the sample included survey respondents including individuals
aged 50 to 75 years, as per the 2008 USPSTF recommendations. For the DID analysis, uninsured
individuals with equivalent age groups for each CRC cancer screening were included as a control
group because they were not impacted by this provision. Individuals under Medicaid coverage
were excluded since participating in Medicaid expansion under the ACA was optional for states
(Wilensky and Gray, 2013). Individuals with colon cancer, had surgery, or were diagnosed with
conditions related to colon cancer were excluded from the sample. In addition, individuals were
excluded if they had missing responses for the required period.
Table 7. Specific Guideline and Study Population for CRC Cancer Screening
Preventive Service
(year)

Colorectal cancer
screening (2008)

Recommendation (grade)
The USPSTF recommends
screening for CRC cancer using
fecal occult blood testing
(FOBT), sigmoidoscopy, or
colonoscopy for adults aged 50
to 75 years. (A)

Study Target
Population
Adults aged
50-75 and not
diagnosed
with colon
cancer

Screening interval
Colonoscopy: every
10 years
Sigmoidoscopy:
every 5 years when
combined with
FOBT
Blood stool test:
every year

Source: US Preventive Services Task Force Website

Aim 2-Analysis
To address objective 1, a proportions test was conducted to illustrate the proportion of
individuals who received FOBT, colonoscopy and/or sigmoidoscopy out of the number of
individuals who were recommended to receive them, before and after the ACA provision. In
addition, to determine if there was a significant difference between the values before and after the
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policy provision, two samples t-tests were conducted. T-tests were performed under the
assumption that variables fit a normal distribution. Table 12 shows the results of proportions test
for FOBT, colonoscopy, and sigmoidoscopy. Furthermore, a trend analysis was performed
visualizing yearly rates of being up-to-date on these CRC cancer screenings before and after the
policy in order to see if there were changes overtime. Figure 4, 5, and 6 demonstrate the change in
FOBT, colonoscopy and/or sigmoidoscopy utilization rates before and after the ACA provision.
To address objective 2, logistic regression models were estimated to measure the receipt of
FOBT, colonoscopy and sigmoidoscopy controlling for all the predisposing, enabling, and need
variables that are listed in table 5. For the DID models, estimates of the impact of the policy were
determined by fitting four logistic regression models for each screening service. The first model
was an unadjusted model that only controlled for the insurance status and the period of screening
(whether or not it was pre-or post the ACA). The second model was an adjusted model that
controlled for predisposing variables including age, race, ethnicity, marital status, education and
employment. The third model was further adjusted by controlling for enabling factors including
income, regular source of care, number of visits to care, region and residence. The fourth and final
regression model was further adjusted by controlling for need factors including perceived health
status, number of chronic conditions, smoking status, and BMI. To select the model with the best
possible fit, AIC values were generated to show the quality of each model. The fourth model,
which is the full model, had the lowest AIC, indicating that it is the best fit for the logistic
regression estimation. The regression models estimated the odds ratios for all the independent
variables and the corresponding 95% confidence intervals. The regression analysis tested all
individuals who had at least one recommended CRC screening against the independent variables
that could have an influence on the individual’s decision to obtain the screenings.
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The logistic regression model was estimated using a DID method. The DID was
implemented as an interaction term between the time variable, POST, and the treatment group
variable, INSURED in the logistic regression model. By using this method, a comparison of
utilization of CRC cancer screenings was conducted between insured and uninsured individuals,
before and after the ACA. The first DID model examined the receipt of FOBT. The second DID
model examined the receipt of colonoscopy. The third DID model examined the receipt of
sigmoidoscopy.
Aim 2-Model Specifications
Model Specification 3 (for FOBT):
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε
For the model estimated in this analysis, the DID estimation is explained by Y, which is the
outcome of interest being the utilization rate of FOBT, INSURED is a dummy variable equal to 1
when individuals were insured and 0 when individuals were uninsured, POST is a time dummy
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables.
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the
control group. It is equal to the difference in utilization among the uninsured (the control group)
after the ACA provision. The coefficient β2 is the difference between the control and treatment
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of
interest β3 which is the difference in differences term. It represents the difference of changes over
time. β3 is the DID estimator that measures the effect of the policy intervention on insured
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individuals. Finally, the coefficient βn represents how Y changes when a single covariate changes
holding other variables in the model constant.
Model Specification 4 (for colonoscopy):
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε
For the model estimated in this analysis, the DID estimation is explained by Y, which is the
outcome of interest being the utilization rate of colonoscopy, INSURED is a dummy variable equal
to 1 when individuals were insured and 0 when individuals were uninsured, POST is a time dummy
variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the time is
before the ACA policy intervention, X is a vector of predisposing, enabling, and need variables.
The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for the control
group, when all control variables are equal to zero. The coefficient β1 is the time trend in the
control group. It is equal to the difference in utilization among the uninsured (the control group)
after the ACA provision. The coefficient β2 is the difference between the control and treatment
groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the coefficient of
interest β3 which is the difference in differences term. It represents the difference of changes over
time. β3 is the DID estimator that measures the effect of the policy intervention on insured
individuals. Finally, the coefficient βn represents how Y changes when a single covariate changes
holding other variables in the model constant.
Model Specification 5 (for sigmoidoscopy):
Y=β0 + β1*POST + β2*INSURED + β3*POST *INSURED+ ∑Xβn + ε
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For the model estimated in this analysis, the DID estimation is explained by Y, which is the
outcome of interest being the utilization rate of sigmoidoscopy, INSURED is a dummy variable
equal to 1 when individuals were insured and 0 when individuals were uninsured, POST is a time
dummy variable equal to 1 if the time is after the ACA policy intervention and equal to 0 if the
time is before the ACA policy intervention, X is a vector of predisposing, enabling, and need
variables. The coefficient β0 is the Y intercept, the utilization for the pre-intervention period, for
the control group, when all control variables are equal to zero. The coefficient β1 is the time trend
in the control group. It is equal to the difference in utilization among the uninsured (the control
group) after the ACA provision. The coefficient β2 is the difference between the control and
treatment groups pre- intervention. The coefficient of the interaction (POST*INSURED) is the
coefficient of interest β3 which is the difference in differences term. It represents the difference of
changes over time. β3 is the DID estimator that measures the effect of the policy intervention on
insured individuals. Finally, the coefficient βn represents how Y changes when a single covariate
changes holding other variables in the model constant.
RESULTS
Table 8 provides descriptive statistics of the predisposing, enabling, and need factors for
the study sample before and after the implementation of the ACA cost-sharing elimination
provision. For the total study sample, 228,777 eligible adults were identified, (77,381 before (2008
to 2010) and 151,396 after (2011 to 2016)) ACA. The majority of the sample were adults who are
less than 65 years old, non-Hispanic white, living in metropolitan area and insured. An independent
two sample t-test “equal variances assumed” to compare the means for all model variables before
and after the ACA was conducted. The results indicated that there is a statistically significant
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difference between the means of most model variables. The mean age for the pre-ACA sample
was 38.64 years, while the mean age for the post sample was 40.10 years (p<0.001). Females were
51% of the sample both pre-and post ACA. The percent of married individuals was 44% pre and
43% post ACA (p<0.001). Although statistically significant differences exist in the means of most
demographic variables, the differences are likely attributable to the large sample size hence these
differences are not meaningful. In general, there were changes in proportions in the different race
groups. The percentage of Whites decreased significantly post ACA (72% to 70%, (p<0.001),
while the percentage of Blacks increased (17% to 18% , p= 0.0158). Hispanics were 24% of the
sample pre and 27% post ACA (p<0.001). Education was significantly different on all levels, with
a decrease for less than high school education from (31% to 29%, p<0.001) and for high school
education from (27% to 24%, p<0.001), in contrast, there was an increase for some college
education from (20% to 24%, p<0.001) and for four-year of college or more from (21% to 23%,
p<0.001). For employment, 66% of the sample was employed for some part of the year. The mean
income was $25,338 pre and $28,994 post ACA (p<0.001). Insured individuals represented 77%
of the sample in the pre ACA period and 78% post ACA (p<0.001). Among all US regions, 20%
of the sample lived in the Midwest pre and 19% post ACA (p<0.001). There was no statistical
significance observed for other regions. For residence, 86% lived in a metropolitan area pre ACA
and 88% post ACA (p<0.001). Of the participants, 66% thought they had excellent, very good
health or good health pre-and post ACA, however, this was not statistically significant. Annually,
a person visited their provider 4.10 visits during the pre ACA period and 4.38 visits post ACA
(p<0.001). Of the participants, 12% smoked before the ACA, and 10% smoked after the ACA
(p<0.001). The mean BMI of the sample was 27.71 pre-and 27.97 post ACA (p<0.001), indicating
individuals are typically overweight. Table 8 shows the means and/or proportions of all model

55

variables with t-test results from comparison of their means.
Table 8. Comparison of Means: T-test Results for Model Variables
Pre-ACA

Post ACA

(n=77,381)

(n=151,396)

P-Value*

38.64 (21.17)

40.10 (21.17)

<0.001

Female- (%)

0.51

0.51

0.54

Race- (%)
White
Black
Native
Asian
Pacific Islander
Multiple

0.72
0.17
0.01
0.07
0.00
0.02

0.70
0.18
0.01
0.08
0.00
0.03

<0.001
0.02
<0.001
<0.001
<0.001
<0.001

Hispanic- (%)

0.24

0.27

<0.001

Married (yes)- (%)

0.44

0.43

<0.001

Education- (%)
Less Than HS
High School
Some College
4 years of college or +

0.31
0.27
0.20
0.21

0.29
0.24
0.24
0.23

<0.001
<0.001
<0.001
<0.001

Employed

0.66

0.66

0.13

Income-Mean
(SD)
Insured- (%)

$25,338
($31262)
0.77

$28,994
($35526)
0.78

<0.001

Region- (%)
Northeast
Midwest
South
West

0.14
0.20
0.38
0.27

0.14
0.19
0.39
0.27

0.46
<0.001
0.004
0.48

Metropolitan Area (yes)- (%)

0.86

0.88

<0.001

Predisposing Factors
Age-mean (SD)

Enabling Factors
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<0.001

Regular Source of Care (yes)(%)

0.74

0.73

0.1005

4.10 (8.35)

4.38 (9.37)

<0.001

Perceived Health Status-mean
(SD)

2.19 (0.90)

2.19 (0.90)

0.67

No. of Chronic Conditions

1.02(1.53)

1.05(1.53)

<0.001

0.12

0.10

<0.001

27.71(6.05)

27.97(6.26)

<0.001

No. of Annual Visits to
Provider-mean (SD)
Need Factors

Smoker (yes)- (%)
BMI-mean (SD)
Standard errors in parentheses
+ p<.1, * p<.05, ** p<0.01, *** p<0.001
*
Two-sample t-test

Results for Aim 1, Objective 1
Table 9 illustrates the number of women eligible and utilization proportions of
mammography and pap smear before and after the ACA provision. An independent two sample ttest “equal variances assumed” to compare utilization rates before and after the ACA was
conducted. The results are irrespective of all other variables that were later included in the
regression analysis. Of the 10,240 eligible women for mammography who participated in the
MEPS survey pre-ACA (2008 to 2010), 72% were considered up-to-date. After the ACA (2011 to
2016), 71% of the 21,967 eligible women were considered up-to-date on mammography, however,
the reduction in mammography utilization was not statistically significant. For pap smear, 78%
were considered up-to-date of the 25,114 eligible women pre ACA while 76% of the 49,679
eligible women were considered up to date post ACA (p<0.001). Surprisingly, utilization of the
pap smear test decreased significantly post ACA.
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Table 9. Mammogram and Pap Smear Proportions Test

Mammogram
Pap Smear

Pre-ACA
Proportion
(n)
Recommended
0.72
(10240)
0.78
(25114)

Post ACA
Proportion
(n)
Recommended
0.71
(21967)
0.76
(49679)

P-Value
0.2422
<0.001

Temporal trends of the proportion of individuals utilizing mammography and pap smear,
among insured and uninsured women, pre-and post ACA were examined using the longitudinal
data file. Figure 2 demonstrates the change in utilization proportion of women over time that are
considered “up-to-date” on mammography based on recommended guidelines. However, Figure 2
only illustrates the unadjusted rate of mammography use for both treatment and control groups
over the period of the study. Rates of mammography have remained approximately the same
during both periods for insured women, however, rates have slightly decrease post ACA among
uninsured women. Figure 3 demonstrates the change in rates of pap smear use over time for insured
and uninsured women. Rates of pap have slightly decreased post ACA among the both insured and
uninsured women. The results illustrated in the trend figures 2 and 3 are surprisingly similar to the
results from the Procedure Proportions Test in table 9. However, the effect that are detected in
figures 2 and 3 could be biased by other factors that differentiate insured women from uninsured
women, therefore, there is a need for adjusted analyses controlling for predisposing, enabling, and
need factors that may impact the use of mammography and pap smear.
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Figure 2. Rate of Mammography Use in Insured and Uninsured Women, 2008-2016

Figure 3. Rate of Pap Smear Use in Insured and Uninsured Women, 2008-2016
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Results for Aim 1, Objective 2
To measure the receipt of mammography and pap smear, before and after the
implementation of the ACA cost-sharing elimination provision, two logistic regressions were
utilized. The models predict whether a woman received a mammography and/or pap smear based
on the selected predisposing, enabling and need predictors. The results of the logistic regression
models examining mammography and pap smear are presented in Tables 10 and 11, respectively.
The tables include proportional odds ratios with the confidence intervals given the other model
variables.
There were 13,128 women who received a mammogram during the expected interval.
Insured women were 82% more likely to receive a mammogram than uninsured women at any
point during the study period (OR=1.82, 95% CI=1.56, 2.13, p=0.001). There was no change in
mammography screening rates among uninsured women before and after the ACA provision.
After the ACA, insured women were 10% more likely than uninsured women to receive a
mammogram, however, this was not statistically significant.
Predisposing Factors
After controlling for all other variables. For each year older, women were 16% more likely
to receive a mammogram (OR=1.16, 95% CI=1.03, 1.30, p<0.05). Hispanic women were
approximately 66% more likely than non-Hispanic women to receive a mammogram (OR=1.66,
95% CI=1.44, 1.91, p<0.001). For the variable race, black women were 53% more likely than
white women to receive a mammogram (OR=1.53, 95% CI=1.35, 1.73, p<0.001), women from
multiple races were 39% less likely than white women to get a mammogram (OR=0.605, 95%
CI=0.43, 0.86, p<0.01); however, the results for all other races were not statistically significant.
Married women were 34% more likely than non-married women to receive a mammogram
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(OR=1.34, 95% CI=1.23, 1.47, p<0.001). For education, women with less than a high school
education were 14% less likely than women with a high school education to get a mammogram
(OR=0.86, 95% CI=0.76, 0.98, p<0.05). In addition, women with 4 years of college education or
more were 26% more likely than women with a high school education to get a mammogram
(OR=1.26, 95% CI=1.11, 1.42, p<0.001). The results for employment were not statistically
significant.
Enabling Factors
After controlling for all other variables, women who lived in the Midwest were 19% less
likely than women who lived in the Northeast to get a mammogram (OR=0.81, 95% CI=0.69, 0.64,
p<0.01); however, results were not statistically significant for other regions and residence in a
metropolitan area. If a woman’s income was doubled, she was 12% more likely to get a
mammogram (OR=1.12, 95% CI=1.08, 1.17, p<0.001). A woman with regular source of care was
172% more likely to receive a mammogram (OR=2.72, 95% CI=2.41, 3.06, p<0.001). Each
additional annual visit to a health provider results in a woman being 9% more likely to receive a
mammogram (OR=1.09, 95% CI=1.08, 1.1, p<0.001).
Need Factors
Interestingly, one unit increase in perceived health status decreased the likelihood that a
woman received a mammogram by 31% (OR=0.69, 95% CI=0.65, 0.73, p<0.001). Each additional
chronic condition increased the likelihood of a woman receiving a mammogram by 40%
(OR=1.40, 95% CI=1.31, 1.50, p<0.001). A woman who smoked was about 40% less likely to get
a mammogram than a woman who did not smoke (OR=0.6, 95% CI=0.53, 0.68, p<0.001). Results
were not statistically significant for BMI.
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Table 10. Logistic Regression Results for Mammography

Mammogram
Independent Variables
Post
Insurance
Insurance * Post
Covariates:
Predisposing Factors
Age
Age Squared
Race (white base)
Black
Native
Asian
Pacific Islander
Multiple
Hispanic
Married
Education (HS base)
Less Than HS
Some College
Four-Year College+
Employed
Enabling Factors
Region (Northeast base)
Midwest
South
West
Metropolitan Area
ln(Income)
Regular Source of Care
Visits
Visits Squared
Need Factors
Perceived Health Status
Chronic Conditions Count
Chronic Conditions
Squared

Odds Ratio

95% CI

P-Value

0.83
1.82
1.10

0.67,1.03
1.56,2.13
0.87,1.40

0.095+
0.000***
0.436

1.16
0.99

1.03,1.30
0.99,1.00

0.012*
0.003**

1.53
0.67
0.84
0.87
0.61
1.66
1.34

1.35,1.73
0.43,1.06
0.71,1.01
0.43,1.76
0.43,0.86
1.44,1.91
1.23,1.47

0.000***
0.088+
0.066+
0.7
0.006**
0.000***
0.000***

0.86
1.05
1.26
0.92

0.79,0.98
0.94,1.18
1.11,1.42
0.81,1.04

0.027*
0.38
0.000***
0.159

0.81
0.96
0.94
0.94
1.12
2.72
1.09
0.99

0.70,0.94
0.84,1.09
0.81,1.09
0.83,1.06
1.08,1.17
2.41,3.06
1.08,1.10
0.99,1.00

0.005**
0.54
0.41
0.28
0.000***
0.000***
0.000***
0.000***

0.69
1.40
0.96

0.65,0.73
1.31,1.50
0.95,0.97

0.000***
0.000***
0.000***

62

Smoker
BMI
N
AIC

0.6
0.99

0.53,0.68
0.99,1.00

0.000***
0.32

13,128
12895.4

Exponentiated coefficients; Standard errors in parentheses
+ p<.1, * p<.05, ** p<0.01, *** p<0.001

There were 30,945 women who received a pap smear during the expected interval. Women
with insurance were 42% more likely to receive a pap smear than women without insurance at any
point during the study period (OR=1.42, 95% CI=1.29, 1.56, p<0.001). There was no effect on
pap smear among uninsured women before and after the ACA provision. After the ACA, insured
women were 1% more likely to receive a pap smear, however, this was not statistically significant.
Predisposing Factors
After controlling for all other variables. For the linear term of age, each year older, women
were 10% more likely to receive a pap smear (OR=1.1, 95% CI=1.08, 1.12, p<0.001). Hispanic
women were 47% more likely than non-Hispanic women to receive a pap smear (OR=1.47, 95%
CI=1.34, 1.59, p<0.001). For the variable race, Black women were 66% more likely than White
women to receive a pap smear (OR=1.66, 95% CI=1.52, 1.82, p<0.001). Asian women were 45%
less likely than White women to receive a pap smear (OR=0.55, 95% CI=0.49, 0.61, p<0.001),
however, the results for all remaining races were not statistically significant. Married women were
38% more likely than non-married women to receive a pap smear (OR=1.38, 95% CI=1.3, 1.5,
p<0.001). For education, women with some college education were 24% more likely than women
with high school education to get a pap smear (OR=1.24, 95% CI=1.14, 1.34, p<0.001). In
addition, women with 4 years of college education or more were 49% more likely than women
with a high school education to receive a pap smear (OR=1.49, 95% CI=1.36, 1.62, p<0.001). The
impact of employment was not statistically significant.
Enabling Factors

63

For enabling factors, region was not significant, however, women who lived in a
metropolitan area were 22% more likely than women who did not live in a metropolitan area to
receive a pap smear (OR=1.22, 95% CI=1.12, 1.34, p<0.001). In regards to income, when a
woman’s income was doubled, she was 7% more likely to get a pap smear (OR=1.07, 95%
CI=1.04, 1.09, p<0.001). A woman with regular source of care was 104% more likely to receive
a pap smear (OR=2.04, 95% CI=1.9, 2.19, p<0.001). With one more visit to a health care provider
per year, a woman was 7% more likely to receive a pap smear (OR=1.07, 95% CI=1.06, 1.08,
p<0.001).
Need Factors
For one unit increase in perceived health status, a woman was 19% less likely to get a pap
smear (OR=0.81, 95% CI=0.78, 0.85, p<0.001). With having one more chronic condition, a
woman was 17% more likely to receive a pap smear (OR=1.17, 95% CI=1.11, 1.24, p<0.001). A
woman who smoked was about 14% less likely to get a pap smear than a woman who did not
smoke (OR=0.86, 95% CI=0.79, 0.93, p<0.001). For one unit increase in BMI, a woman was 1%
less likely to receive a pap smear (OR=0.99, 95% CI=0.99, 1.00, p<0.05).
Table 11. Logistic Regression Results for Pap smear
Pap Smear
Post
Insurance
Insurance * Post
Predisposing Factors
Age
Age Squared
Race (White Base)
Black
Native
Asian

Odds Ratio

95% CI

P-Value

0.94
1.42
1.01

0.84,1.05
1.30,1.56
0.88,1.16

0.28
0.000***
0.88

1.10
0.99

1.08,1.12
0.99,0.99

0.000***
0.000***

1.66
1.28
0.55

1.52,1.82
0.92,1.78
0.49,0.61

0.000***
0.15
0.000***
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Pacific Islander
Multiple
Hispanic
Married
Education (HS Base)
Less Than HS
Some College
Four-Year College+
Employed
Enabling Factors
Region (Northeast base)
Midwest
South
West
Metropolitan Area
ln(Income)
Regular Source of Care
Visits
Visits Squared
Need Factors
Perceived Health Status
Chronic Conditions
Count
Chronic Conditions
Squared
Smoker
BMI
N
30,945
AIC
27593.46

0.90
0.83
1.46
1.38

0.57,1.40
0.65,1.07
1.34,1.60
1.30,1.48

0.63
0.15
0.000***
0.000***

1.06
1.24
1.49
0.93

0.96,1.17
1.14,1.34
1.36,1.62
0.84,1.03

0.25
0.000***
0.000***
0.17

0.92
1.07
0.99
1.22
1.07
2.04
1.07
0.99

0.83,1.02
0.97,1.18
0.90,1.10
1.12,1.34
1.04,1.10
1.90,2.20
1.06,1.08
0.99,1.00

0.13
0.18
0.94
0.000***
0.000***
0.000***
0.000***
0.000***

0.81
1.17

0.78,0.85
1.11,1.24

0.000***
0.000***

0.97

0.96,0.98

0.000***

0.86
0.99

0.79,0.94
0.98,0.99

0.001***
0.012*

Exponentiated coefficients; Standard errors in parentheses
+ p<.1, * p<.05, ** p<0.01, *** p<0.001

Results for Aim 2, Objective 1
Table 12 illustrates the number of individuals eligible and utilization proportions of FOBT,
colonoscopy and sigmoidoscopy before and after the ACA provision. An independent two sample
t-test “equal variances assumed” was performed to compare utilization rates before and after the
ACA. The results are irrespective of all other variables that were later included in the regression
analysis. Of the 20,183 eligible individuals for FOBT, 12% were considered up-to-date pre-ACA
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and 11% of 43,497 post ACA. For colonoscopy, 50% were considered up-to-date of the 13,841
eligible individuals pre-ACA while 54% of the 43,497 individuals were considered up-to-date post
ACA. For sigmoidoscopy, 6% were considered up-to-date of the 13,841 eligible individuals preACA while 4% of the 43,497 individuals were considered up-to-date post ACA. The results were
not statistically significant for FOBT, however, they were statistically significant for colonoscopy
and sigmoidoscopy (p<0.001). Surprisingly, utilization of sigmoidoscopy decreased significantly
post ACA and the utilization of colonoscopy was the only CRC cancer screening procedure that
increased significantly post ACA.
Table 12. FOBT, Colonoscopy and Sigmoidoscopy Proportions Test

Blood Stool
Colonoscopy
Sigmoidoscopy

Pre-ACA
Proportion
(n)
Recommended

Post ACA
Proportion
(n)
Recommended

0.12
(20,183)
0.50
(13,841)
0.06
(13,841)

0.11
(43,497)
0.54
(43,497)
0.04
(43,497)

P-Value
0.0730
<0.001
<0.001

Figure 4, 5 and 6 illustrate the unadjusted utilization rate of FOBT, colonoscopy, and
sigmoidoscopy for both treatment and control groups over the period of the study. Rates of FOBT
have remained the same pre-ACA but suddenly decreased from 2011 to 2012 for both groups.
Colonoscopy rates slightly increased for insured women compared to uninsured women post ACA.
Sigmoidoscopy rates decreased similarly for both groups throughout the study period. The results
illustrated in the figures 4,5 and 6 are surprisingly similar to the results from the Procedure
Proportions Test in table 9. However, the effect that we detect in figures 4, 5 and 6 could be biased
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by other factors that differentiate insured individuals from uninsured individuals, therefore, there
was a need for adjusted analyses that controls for predisposing, enabling, and need factors that
impact the use of CRC cancer screenings.
Figure 4. Rate of FOBT Use in Insured and Uninsured Individuals, 2008-2016
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Figure 5. Rate of Colonoscopy Use in Insured and Uninsured Individuals, 2008-2016

Figure 6. Rate of Sigmoidoscopy Use in Insured and Uninsured Individuals, 2008-2016
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Results for Aim 2, Objective 2
To measure the receipt of FOBT before and after the implementation of the ACA costsharing elimination provision, a logistic regression was utilized. The model predicts whether an
individual received a FOBT based on the selected predisposing, enabling and need predictors. The
results of logistic regression model are presented in Table 13. The table includes proportional odds
ratios for the model with the confidence intervals for the odds ratios knowing the other predictors
are in the model.
In table 13, there were 26,728 individuals who were up-to-date on FOBT. There was no
effect on FOBT among uninsured individuals before and after the ACA provision. Individuals with
insurance were 47% more likely to get a FOBT than individuals without insurance at any point
during the study period (OR=1.47, 95% CI=1.22, 1.78, p<0.001). After the ACA, insured
individuals were approximately 4.3% more likely to get a FOBT, however, this was not statistically
significant.
Predisposing Factors
After controlling for all other variables. For the linear term of age, each year older,
individuals were 34% more likely to receive a FOBT (OR=1.34, 95% CI=1.2, 1.49, p<0.001).
Women were 10% less likely than men to receive a FOBT (OR=0.90, 95% CI=0.83, 0.97, p<0.01).
Hispanics were approximately 41% more likely than non-Hispanics to receive a FOBT (OR=1.41,
95% CI=1.25, 1.6, p<0.001). For the variable race, Black individuals were 39% more likely than
White individuals to receive a FOBT (OR=1.39, 95% CI=1.25, 1.55, p<0.001), however, the
results for all other races were not statistically significant. For education, individuals with less than
high school education were 14% less likely than individuals with high school education to receive
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a FOBT (OR=0.86, 95% CI=0.75, 0.98, p<0.05). In addition, individuals with some college
education (OR=1.21, 95% CI=1.09, 1.35, p<0.001) and individuals with 4 years of college
education or more (OR=1.19, 95% CI=1.07, 1.32, p=0.001) were more likely than individuals with
high school education to receive a FOBT. Employed people were 18% less likely than unemployed
people to receive a FOBT (OR=0.82, 95% CI=0.74, 0.92, p<0.001).
Enabling Factors
For enabling factors, individuals who lived in the South (OR=1.24, 95% CI=1.1, 1.4,
p=0.001) and individuals who lived in the West region (OR=1.90, 95% CI=1.68, 2.15, p=0.001)
were more likely than individuals who lived in the Northeast to receive a FOBT. Individuals who
lived in a metropolitan area were 27% more likely to receive a FOBT (OR=1.27, 95% CI=1.13,
1.43, p=0.001). When an individual’s income was doubled, he/she was 7% more likely to receive
a FOBT (OR=1.07, 95% CI=1.03, 1.11, p<0.01). A person with regular source of care was 137%
more likely to receive a FOBT than a person without regular source of care (OR=2.37, 95%
CI=2.01, 2.8, p<0.001). With one more visit to a health provider per year, a person was 3% more
likely to receive a FOBT (OR=1.03, 95% CI=1.02, 1.04, p<0.001), in other words, the more office
visits individuals had the more likely they received FOBT.
Need Factors
For one unit increase in perceived health status, a person was 5% less likely to receive a
FOBT, however, this was not significant. With having one more chronic condition, a person was
19% more likely to receive a FOBT (OR=1.19, 95% CI=1.12, 1.27, p<0.001). Results for smoking
and BMI were not statistically significant.
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Table 13. Logistic Regression Results for FOBT
Blood Stool
Post
Insurance
Insurance * Post
Predisposing Factors
Age
Age Squared
Female
Race (White Base)
Black
Native
Asian
Pacific Islander
Multiple
Hispanic
Married
Education (HS Base)
Less Than HS
Some College
Four-Year
College or+
Employed
Enabling Factors
Region (Northeast
base)
Midwest
South
West
Metropolitan Area
ln(Income)
Regular Source of
Care
Visits
Visits Squared
Need Factors
Perceived Health
Status
Chronic Conditions
Count

Odds Ratio

95% CI

P-Value

0.83
1.47
1.04

0.61,1.14
1.22,1.78
0.75,1.45

0.25
0.000***
0.80

1.34
0.99
0.90

1.19,1.49
0.99,0.99
0.83,0.97

0.000***
0.000***
0.009**

1.39
1.29
1.14
1.19
0.84
1.41
1.08

1.25,1.55
0.84,1.97
0.97,1.34
0.68,2.07
0.58,1.21
1.25,1.60
0.99,1.18

0.000***
0.24
0.12
0.54
0.35
0.000***
0.075+

0.86
1.21
1.19

0.75,0.98
1.09,1.35
1.07,1.32

0.027*
0.000***
0.001**

0.82

0.74,0.92

0.000***

1.02
1.24
1.90
1.27
1.07
2.37

0.89,1.18
1.09,1.40
1.68,2.15
1.13,1.43
1.02,1.11
2.01,2.80

0.73
0.001***
0.001***
0.000***
0.002**
0.000***

1.03
1.00

1.02,1.04
1.00,1.00

0.000***
0.000***

0.95

0.90,1.00

0.051+

1.19

1.12,1.27

0.000***

71

Chronic Conditions
Squared
Smoker
BMI
N
AIC

0.99

0.98,0.99

0.002**

0.93
0.99
26,728
18397.23

0.82,1.05
0.99,1.00

0.23
0.42

Exponentiated coefficients; Standard errors in parentheses
+ p<.1, * p<.05, ** p<0.01, *** p<0.001

To measure the receipt of colonoscopy among individuals who were recommended to
receive it, before and after the implementation of the ACA cost-sharing elimination provision, a
logistic regression was utilized. The model predicts whether an individual received colonoscopy
based on the selected predisposing, enabling and need predictors. The results of logistic regression
model are presented in Table 14. The table includes proportional odds ratios for the model with
the confidence intervals for the odds ratios knowing the other predictors are in the model.
In table 14, there were 21,206 individuals who were up-to-date on colonoscopy. There was
no effect on colonoscopy among uninsured individuals before and after the ACA provision.
Individuals with insurance were 111% more likely to receive a colonoscopy than individuals
without insurance at any point during the study period (2008 to 2016) (OR=2.11, 95% CI=1.83,
2.42, p<0.001). After the ACA, insured individuals were approximately 5.1% more likely to get a
colonoscopy, however, this was not statistically significant.
Predisposing Factors
After controlling for all other variables. For the linear term of age, each year older,
individuals were 57% more likely to receive a colonoscopy (OR=1.57, 95% CI=1.44, 1.70,
p<0.001). Women were 10% less likely than men to receive colonoscopy (OR=0.90, 95%
CI=0.84, 0.95, p=0.001). Hispanics were approximately 21% less likely than non-Hispanics to
receive colonoscopy (OR=0.79, 95% CI=0.72, 0.87, p<0.001). For the variable race, Blacks were
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16% more likely than Whites to receive colonoscopy (OR=1.16, 95% CI=1.07, 1.27, p=0.001),
whereas Asians (OR=0.58, 95% CI=0.51, 0.66, p<0.001) and pacific islanders (OR=0.51, 95%
CI=0.32, 0.82, p<0.05) were less likely than whites to receive a colonoscopy. For education,
individuals with less than high school education were 16% less likely than individuals with high
school education to receive colonoscopy (OR=0.84, 95% CI=0.76, 0.93, p=0.001). In addition,
individuals with some college education (OR=1.18, 95% CI=1.09, 1.28, p<0.001) and individuals
with 4 years of college education or more (OR=1.45, 95% CI=1.34, 1.58, p<0.001) were more
likely than individuals with high school education to receive colonoscopy. Employed people were
21% less likely to get a colonoscopy than unemployed people (OR=0.79, 95% CI=0.73, 0.87,
p<0.001).
Enabling Factors
For enabling factors, individuals who lived in the South (OR=0.90, 95% CI=0.82, 0.98,
p<0.0) and the West (OR=0.73, 95% CI=0.67, 0.81, p<0.001) were less likely than individuals
who lived in the Northeast to receive colonoscopy. Individuals who lived in a metropolitan area
were 20% more likely to receive colonoscopy (OR=1.20, 95% CI=1.10, 1.31, p<0.001). When an
individual’s income was doubled, he/she was 14% more likely to receive colonoscopy (OR=1.14,
95% CI=1.10, 1.17, p<0.001). A person with regular source of care was 139% more likely to
receive colonoscopy than a person without a regular source of care (OR=2.39, 95% CI=2.17, 2.63,
p<0.001). With one more visit to a health provider per year, a person was 7% more likely to receive
colonoscopy (OR=1.07, 95% CI=1.06, 1.07, p<0.001), in other words, the more office visits
individuals had the more likely they received colonoscopy.
Need Factors
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For one unit increase in perceived health status, a person was 14% less likely to get a
colonoscopy (OR=0.86, 95% CI=0.83, 0.9, p<0.001). With having one more chronic condition, a
person was 33% more likely to receive colonoscopy (OR=1.33, 95% CI=1.26, 1.39, p<0.001). A
smoker was 71% less likely to receive a colonoscopy than a non-smoker (OR=0.71, 95% CI=0.65,
0.77, p<0.001). Results for BMI were not statistically significant.

Table 14. Logistic Regression Results for Colonoscopy
Colonoscopy
Post
Insurance
Insurance * Post
Predisposing Factors
Age
Age Squared
Female
Race (White base)
Black
Native
Asian
Pacific Islander
Multiple
Hispanic
Married
Education (HS Base)
Less Than HS
Some College
Four-Year College
or +
Employed
Enabling Factors
Region (Northeast
base)
Midwest
South
West

Odds Ratio

95% CI

P-Value

1.02
2.11
1.05

0.84,1.23
1.83,2.42
0.86,1.29

0.87
0.000***
0.63

1.57
0.99
0.90

1.44,1.70
0.99,0.99
0.84,0.96

0.000***
0.000***
0.001***

1.16
0.73
0.58
0.51
0.94
0.79
1.25

1.07,1.27
0.51,1.03
0.51,0.66
0.32,0.82
0.72,1.24
0.72,0.87
1.17,1.33

0.001***
0.076+
0.000***
0.005**
0.67
0.000***
0.000***

0.84
1.18
1.45

0.76,0.93
1.09,1.28
1.34,1.58

0.001***
0.000***
0.000***

0.79

0.73,0.87

0.000***

0.80
0.90
0.73

0.72,0.88
0.82,0.98
0.67,0.81

0.000***
0.018*
0.000***
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Metropolitan Area
ln(Income)
Regular Source of Care
Visits
Visits Squared

1.20
1.14
2.39
1.07
0.99

Need Factors
Perceived Health Status
0.86
Chronic Conditions
1.33
Count
Chronic Conditions
0.97
Squared
Smoker
0.71
BMI
1.00
N
21,206
AIC
24916.15

1.10,1.31
1.10,1.17
2.17,2.63
1.06,1.07
0.99,1.00

0.000***
0.000***
0.000***
0.000***
0.000***

0.83,0.90
1.26,1.39

0.000***
0.000***

0.96,0.98

0.000***

0.65,0.77
0.99,1.01

0.000***
0.90

Exponentiated coefficients;
+ p<.1, * p<.05, ** p<0.01, *** p<0.001

To measure the receipt of sigmoidoscopy before and after the implementation of the ACA
cost-sharing elimination provision, a logistic regression was utilized. The model predicts whether
an individual received sigmoidoscopy based on the selected predisposing, enabling and need
predictors. The results of logistic regression model are presented in Table 15. The table includes
proportional odds ratios for the model with the confidence intervals for the odds ratios knowing
the other predictors are in the model.
In table 15, there were 21,206 individuals who were up-to-date on sigmoidoscopy. There
was no effect on sigmoidoscopy among uninsured individuals before and after the ACA provision.
Individuals with insurance were 40% more likely to get sigmoidoscopy than individuals without
insurance at any point during the study period (OR=1.40, 95% CI=1.04, 1.89, p<0.05). After the
ACA, insured individuals were 6% less likely to receive sigmoidoscopy, however, this was not
statistically significant.
Predisposing Factors
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Holding all other variables constant, for the linear term of age, each year older, individuals
were 51% more likely to receive a sigmoidoscopy (OR=1.51, 95% CI=1.27, 1.8, p<0.001).
Women were 13% less likely than men to receive sigmoidoscopy (OR=0.87, 95% CI=0.76, 0.98,
p<0.05). Hispanics were approximately 36% more likely than non-Hispanics to receive
sigmoidoscopy (OR=1.36, 95% CI=1.13, 1.65, p=0.001). For the variable race, Black individuals
were 23% more likely than Whites to receive sigmoidoscopy (OR=1.23, 95% CI=1.03, 1.47,
p<0.05). The results for all other races were not significant. For education, individuals with some
college education (OR=1.29, 95% CI=1.09, 1.52, p<0.01) and individuals with 4 years of college
education (OR=1.27, 95% CI=1.07, 1.50, p<0.01) were more likely than individuals with high
school education to receive sigmoidoscopy. Employed people were 10% less likely than
unemployed people to get a sigmoidoscopy, however, this was not significant.
Enabling Factors
For enabling factors, individuals who lived in the West were 44% more likely than
individuals who lived in the Northeast to receive sigmoidoscopy (OR=1.44, 95% CI=1.52, 2.23,
p<0.001). Individuals who lived in a metropolitan area were 35% more likely to receive
sigmoidoscopy (OR=1.35, 95% CI=1.11, 1.64, p<0.01). Results for income were not statistically
significant. A person with regular source of care was 84% more likely to receive a sigmoidoscopy
(OR=1.84, 95% CI=1.44, 2.34, p<0.001). With one more visit to a health care provider per year,
a person was 2% more likely to receive a sigmoidoscopy (OR=1.02, 95% CI=1.01, 1.03, p<0.05),
in other words, the more office visits individuals had the more likely they received sigmoidoscopy.
Need Factors
For one unit increase in perceived health status, a person was 5% more likely to get a
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sigmoidoscopy, however, this was not significant. With having one more chronic condition, a
person was 13% more likely to receive a sigmoidoscopy (OR=1.13, 95% CI=1.03, 1.24, p<0.05).
Results for smoking and BMI were not statistically significant.
Table 15. Logistic Regression Results for Sigmoidoscopy
Sigmoidoscopy
Insurance
Post
Insurance * Post
Predisposing Factors
Age
Age Squared
Female
Race (White Base)
Black
Native
Asian
Pacific Islander
Multiple
Hispanic
Married
Education (HS Base)
Less Than HS
Some College
Four-Year College or+
Employed
Enabling Factors
Region (Northeast base)
Midwest
South
West
Metropolitan Area
ln(Income)
Regular Source of Care
Visits
Visits Squared

Odds Ratio

95% CI

P-Value

1.40
0.77
0.94

1.04,1.89
0.49,1.20
0.59,1.50

0.028*
0.24
0.80

1.51
0.99
0.87

1.27,1.80
0.99,0.99
0.76,0.98

0.000***
0.000***
0.025*

1.23
1.08
1.05
0.30
0.67
1.36
0.93

1.03,1.47
0.54,2.15
0.82,1.34
0.07,1.24
0.35,1.28
1.13,1.65
0.82,1.07

0.020*
0.82
0.72
0.096+
0.227
0.001**
0.30

1.15
1.29
1.27
0.90

0.94,1.41
1.09,1.52
1.07,1.50
0.77,1.07

0.18
0.003**
0.007**
0.23

0.91
0.98
1.84
1.35
1.05
1.84
1.02
1.00

0.74,1.14
0.81,1.19
1.52,2.23
1.11,1.64
0.98,1.12
1.44,2.34
1.01,1.03
1.00,1.00

0.42
0.86
0.000***
0.002**
0.15
0.000***
0.004**
0.045*

Need Factors
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Perceived Health Status
Chronic Conditions Count
Chronic Conditions
Squared
Smoker
BMI
N
21,206
AIC
8529.86

1.05
1.13
0.99

0.97,1.14
1.03,1.24
0.98,1.01

0.22
0.013*
0.56

0.95
1.00

0.78,1.14
0.99,1.01

0.57
0.99

Exponentiated coefficients; + p<.1, * p<.05, ** p<0.01, *** p<0.001
+ p<.1, * p<.05, ** p<0.01, *** p<0.001

DISCUSSION
Our findings show that utilization rates post the ACA cost-sharing elimination provision
did not increase for the examined cancer preventive services including mammography, pap smear,
FOBT, colonoscopy and sigmoidoscopy. Given the decreased cost-sharing, it was expected that
utilization will increase; however, there were some predisposing, enabling, and need factors that
were associated with a change in utilization rates.
The hypotheses for the study aims were that the utilization of cancer screenings will
increase post the ACA cost-sharing elimination among privately and/or Medicare insured
individuals as access to preventive care services increased under the ACA. The reasoning behind
this hypothesis was that the elimination of all types of out-of-pocket would result in a greater
probability of individuals obtaining cancer screenings; however, we did not detect statistically
significant differences in utilization rates between insured and uninsured individuals in the DID
estimation. Current findings agree with some previous studies that suggest lack of evidence of a
positive gain from the ACA cost-sharing elimination provision. In 2015, three different studies
evaluating the ACA provision found no significant change in utilization of breast, CRC and
cervical cancer screenings among privately insured individuals (Mehta et al, 2015; Han et al, 2015;
Jensen et al, 2015). Similarly, a recent study found that changes in the utilization of pap smear,
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mammography, and CRC cancer screenings among the privately insured were not a result of the
ACA (Hong et al, 2017). Prior studies with null findings blamed their results to several factors.
First, many individuals involved in these studies held supplement insurance that covered a
substantial amount or the full cost of cancer preventive services (Jensen et al, 2015). This applies
to our study since the MEPS data does not contain additional information about supplemental
coverage which could impact the results. Second, most of these studies did not have available data
for long periods of time after the ACA. This was a problem because longer time is required to
capture changes in utilization rates especially since all cancer screenings have screening intervals
that are more than a year, however, this study contained data until 2016 which suggests enough
time to observe changes in utilization. Third, cancer screening services are different than other
screenings as they require more resources to be delivered including specialty equipment,
professionals, and specific locations. In addition, from a patient’s perspective, cancer screening
services would require time, geographic accessibility, obtainability of such specialty screenings,
health education and cultural awareness (Han et al, 2015). Lastly, several states already had
existing policies to reduce cost-sharing on preventive care services before the ACA (Kirby et al,
2016). Therefore, there are other barriers that face cancer screenings that are not exclusively
monetary in their types and are not related to cost-sharing.
This study did not consider many psychosocial variables that influence health behavior
including knowledge, attitudes, cultural beliefs, self-efficacy, and perceived threat. These are all
important determinants of screening and even with the removal of cost barriers, they could still
represent important barriers. A few studies have examined the relationship between cultural
beliefs and patterns of cancer preventive care services utilization. For example, research has
shown that cultural beliefs greatly influenced the perceptions of African-American women about
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breast cancer and mammography. A study of African-American and white cancer patients found
that the elderly, less educated, and African-American women were more likely to believe in
nontraditional cancer treatments including salves (a healing ointment) and vitamins (Loehrer et
al, 1991). Another study surveying African-American women showed that the respondents
explained having cancer as a result of a biological process or the will of God (Gregg and Curry,
1994). Finally, a study found that a substantial number of the African-American women were
hesitant to obtain cancer treatment because of their fears about undesirable impacts on their
relationships with their male partners, especially that they would not be physically attractive
(Lannin et al, 1998). By evaluating various cultural barriers, cultural intervention strategies can
be implemented to improve breast cancer screening utilization.
Although current findings agree with prior research that showed no positive association of
the cost-sharing elimination provision and the utilization of preventive care services, they differ
from findings of several studies that showed significant increases in the utilization of preventive
care services after the ACA. Lau and colleagues found a significant increase in the receipt of
routine examination, blood pressure screening, cholesterol screening and the annual dental visit
among young adults (Lau et al, 2014). Similarly, a study of a large community-based health system
found that mammography usage increased significantly among women (Nelson et al, 2015). In
addition, several studies showed a significant increase in mammography utilization among
Medicare beneficiaries after the ACA (Cooper et al, 2016, Sabatino, et al, 2016; Jena et al, 2017).
Those studies suggest positive gains from the ACA cost-sharing elimination provision; however,
many examined a package of preventive services or found a slight increase in cancer screenings
rates. This study examined only cancer preventive screenings and individuals who were eligible
for these screenings who had private or Medicare coverage.
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As mentioned earlier, there were some predisposing, enabling, and need factors that were
associated with a change in utilization rates. The predisposing factors of age, education, and being
Black increased the likelihood of receiving all cancer screenings, with being older and more
educated, individuals had higher rates of cancer screenings after controlling for the other
covariates. Being Hispanic increased the likelihood of receiving all cancer screenings except for
colonoscopy. These findings disagree with prior research as it has shown that minorities, such as
Hispanics and blacks were, in general, less likely than whites to receive preventive services such
as cholesterol screening, blood pressure checks, and cancer screenings (Gornick, 2000). This might
be attributed to having newer policies that increased the access to preventive care for minority
groups. With respect to mammography and pap smear, married women were more likely receive
them. Evaluation of CRC screenings showed that being employed or female decreased the
likelihood of utilizing them.
Enabling factors, such as having a regular source of care and more visits to a health care
provider, increased the likelihood of receiving all cancer screenings. These findings agree with
previous studies as many them found that receipt of preventive care services was strongly
positively associated with having a constant source of care (DeVoe et al, 2003; Bednarek &
Schone, 2003; Bandi et al, 2012; Allen et al, 2009). After controlling for other covariates, higher
income individuals were more likely to receive all cancer screenings except for sigmoidoscopy.
This was expected as previous studies have found that financial requirements tend to reduce the
use of valuable care, especially for vulnerable groups such as low-income individuals (Chernew
et al, 2007; Chandra et al, 2014). Similarly, living in a metropolitan area increased the likelihood
to receive all cancer screenings except for mammography, after controlling for other covariates.
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The need factors in this paper included perceived health status, number of chronic
conditions, smoking status and BMI. After controlling for other covariates, having more than one
chronic condition increased the likelihood of receiving all cancer screenings while having a
lower perceived health status decreased the likelihood of receiving all cancer screenings except
for sigmoidoscopy. Prior research has shown that the number of chronic diseases is correlated
with increased cancer screenings. For example, hypertensive individuals had more breast exams,
pap smears, FOBTs, and a trend to have more mammograms (Heflin et al, 2002). Also, women
with three or more chronic conditions were shown to have more mammograms, pap smears, and
breast exams (Yasmeen et al, 2011; Zao et al, 2008). In our study, smokers were less likely to
receive mammography, pap smear, and colonoscopy. Similarly, prior research has demonstrated
that daily smokers were found to be less likely to receive cancer screening despite their increased
risk of cancer (Vander et al, 2012). In regards to BMI, our study found that women with a higher
BMI were less likely to receive a pap smear. This agrees with literature findings as studies have
shown that that obese women were less likely to receive breast, cervical, or CRC cancer
screening than normal weight women (Reidpath et al, 2002; Wee et al, 2002).
This study had several limitations. The MEPS data contains self-reported answers to survey
questions that are prone to recall error, however, since the error will have a similar effect
throughout the different years, it will not significantly impact the outcomes of this study (Rauscher
et al., 2008). In addition, the MEPS is cross-sectional panel data that only captures information at
the point of the survey which might result in biased impact effects of some variables. Furthermore,
the MEPS lacks data about supplemental coverage which might impact the results. Another
limitation of this study is including uninsured individuals as a control group in the DID estimation.
Uninsured individuals could be substantially different from insured individuals in utilization trends
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of preventive care services before the implementation of the ACA provision. Those who are
uninsured served as the control group because the implementation of the ACA provision did not
affect them. The DID approach requires a control group that is very similar to the treatment group;
however, there are some differences between the uninsured and insured individuals. The
Uninsured are more likely to be low-income, Hispanic, and young (Kaiser Family Foundation,
2013). Nevertheless, since the implementation of the ACA has been a gradual system among all
forms of insurance types, the uninsured were the single group that remained constant before and
after the implementation of the ACA, which is the reason they were selected to serve as the control
group.
CONCLUSION
Based on the findings of this study, the ACA cost-sharing elimination provision was not
associated with an expected increase in utilization of preventive care services among Medicare
and privately insured individuals. Despite the theories that out-of-pocket expenses are a barrier to
preventative care utilization, the findings of this study and those of other researchers do not support
them. Additional efforts might be necessary to complement the ACA cost-sharing elimination
provision (Hong et al, 2017). These efforts would include enhancing the knowledge of people
about the importance of preventive screenings in detecting cancer at an early stage,
before symptoms appear, where treatment is easier and more successful to cure them and
eventually save their lives. In addition, efforts in outreach and implementing educational
campaigns to raise public awareness about the available health service benefits may increase
awareness. In conclusion, the results of this study which supports the work of prior researchers
suggest that future research is necessary to understand and evaluate the impact of cost-sharing on
access to cancer preventive care services.
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